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ABSTRACT 
The overall aim of this thesis was to describe impact on life up to ten years after 
intracranial aneurysm rupture in terms of health-related quality of life, changes in 
everyday life and descriptive epidemiology with the intention to contribute to an 
increased understanding of the long-term perceived consequences of that impact. 
 
Study I aimed to describe changes and transitions in everyday life during the first two 
years following an intracranial aneurysm rupture. A consecutive sample of 88 patients 
was followed-up at three time points. A majority of respondents perceived changes in 
their everyday life during the first two years following aneurysm rupture. Transitions 
were revealed within changes in personality, changed social roles and relationships, and 
changed abilities and behavior. 
     In Study II epidemiology in relation to gender differences and treatment modalities 
ten years after aneurysm rupture was investigated. Ten years after the onset, 63.9% of 
the 468 admitted patients were still alive. The incidence in women was higher than that 
of men; they were older at onset and were diagnosed with more aneurysms. There were 
no significant differences in survival times between patients treated with different 
active aneurysm treatments, or between men and women. 
     In Study III survivors from study II (n=217) were followed-up with questionnaires 
and telephone interviews, aiming to describe psychological, physical and cognitive 
functions ten years after intracranial aneurysm rupture. Compared to reference groups, 
the aneurysm respondents scored higher levels of anxiety and depression. Respondents 
with ruptured aneurysms in the posterior circulation of the brain scored significantly 
more symptoms of anxiety and depression. A small proportion, 2.8%, scored for severe 
physical disability and 21.7% scored below the cut-off value, indicating cognitive 
impairments. 
     Study IV used the same sample as study III (n=217), and a general population 
sample (n=434) from the Stockholm Public Health Survey, matched by age and sex. 
The aim was to measure health-related quality of life (HRQoL), and to explore factors 
affecting HRQoL, ten years after intracranial aneurysm rupture. Compared to general 
population, the aneurysm sample reported significantly more problems with mobility, 
self-care, usual activities and anxiety/depression and had significantly lower overall 
HRQoL values. HRQoL in the aneurysm sample was most affected in respondents with 
worse neurological outcome, respondents with comorbidities, and respondents with low 
perceived recovery. 
      
In conclusion, intracranial aneurysm ruptures impacts upon life in several ways for an 
extensive period of time after the onset. The results indicate a need for follow-up and 
support, and to identify subgroups of aneurysm patients who might benefit from 
support: patients with ruptured aneurysms in the posterior circulation of the brain; 
patients with worse neurological outcome at hospital discharge; patients with 
comorbidities; and patients with low perceived recovery. 
     Ten years after the onset of aneurysm rupture the majority of patients were still 
alive. Differences between men and women were apparent in incidence and clinical 
presentation at the onset of aneurysm rupture, not in survival times. Survival time was 
equal between patients within active treatment modalities. 
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1 INTRODUCTION 
 
My clinical experience of patients suffering from ruptured intracranial aneurysms is 
both as an operating room nurse, and as a center coordinator in a multicenter study 
(International Study of Unruptured Intracranial Aneurysms, ISUIA) during a period of 
seven years, with yearly follow-up with questionnaires and telephone interviews. Over 
four years I also conducted telephone follow-ups one year after rupture, of all patients 
treated for ruptured intracranial aneurysms at the clinic. Some patients described that 
they had returned to their former life, while others described that life was „upside-
down‟ despite having a good neurological outcome at hospital discharge. During the 
follow-up calls it became evident that they needed someone to talk to about their 
experiences, and more information about the expectations around their condition.  A 
large proportion described suffering from increased anxiety. Some of the patients 
expressed a need for support, and were dissatisfied with the fact that their caregivers in 
primary health care lacked knowledge and understanding of the specific problems they 
had experienced in the aftermath of intracranial aneurysm rupture.  
     The literature provides several descriptions of how aneurysm ruptures impact upon 
different aspects of health and life, but information on the perceived long-term 
consequences, beyond the first 18 months after the rupture, is insufficient. 
 
This doctoral thesis is an attempt to contribute to an increased understanding of the 
long-term perceived consequences from which patients suffer after intracranial 
aneurysm rupture.  
 2 
 
2 BACKGROUND 
 
2.1 HEALTH, HEALTH STATUS AND HEALTH STATE 
Health is an essential core component in the nursing discipline, but is also central to 
other disciplines, such as in medicine and public health.
1
 In 1946, the World Health 
Organization (WHO) formulated a definition of health that is commonly used within 
different disciplines: “a state of complete physical, mental and social well-being and 
not merely the absence of disease or infirmity”.2 (p.2)       
     In the literature, health has been conceptualized in different ways: in a classical 
scientific perspective described by the medical and molecular indications of the 
presence or absence of illness; or in a psychological perspective where health and 
illness are expressions of deeper meanings and personality is related to behavioral 
approaches of stress reduction. Other views of health in the literature are: the 
preventive/promotional perspective, where risk assessments, self-care and individual 
choices play an important role; the social/political perspective that addresses the role of 
the environment; and the metaphorical perspective where the meanings of health are 
found in intuition and symbolism.
1
 In nursing, the territory for theoretical development 
that unifies these different views of health are:  human responses to health and illness 
situations, the subjective world of ill or healthy clients, self-care behaviors in health and 
illness, therapeutic actions that enhance recovery and well-being, client-nurse 
interactions, client-environment interactions, and coping styles.
 1
 
 
Health may be described in the context of health status or health state. Health status has 
been defined by WHO
3
 to be a description of and/or a measurement of the health of an 
individual or a population at a specified time point, and against identifiable standards or 
health indicators. 
     A health state can include different dimensions of health status, which allows 
creating health profiles and overall measures of health in one single number. In health-
related quality of life research there are two types of health states; the self-state of the 
respondent during a given period of time, and hypothetical health states that the 
respondent may, or may not have experienced.
4
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2.2 QUALITY OF LIFE AND HEALTH-RELATED QUALITY OF LIFE  
In order to understand the perceived consequences of an illness, and to compare 
different treatments or to improve care, quality of life measures can be used.
5
 WHO 
have defined quality of life (QoL) as “individuals‟ perception of their position in life in 
the context of the culture and value systems in which they live and in relation to their 
goals, expectations, standards and concerns”.6 (p. 1405) QoL is a broad-ranging concept 
that includes both positive and negative aspects of life.
6
 Fayers & Machin
5
 describe 
QoL as a latent construct; it is a hypothetical concept that is assumed to exist, but is not 
possible to directly measure or observe, since QoL means different things to different 
people.  
     QoL aspects that directly relate to an individual‟s health are referred to as health-
related quality of life (HRQoL).
7
 There is a general agreement that QoL and HRQoL 
are subjective parameters that can only be assessed by the patient (or person) self, and 
proxy assessments are only used if the person is unable to make a coherent response. 
For that reason, outcomes in HRQoL studies are also referred to as PRO (patient-
reported outcomes, or person-reported outcomes, as participants in all studies are not 
always patients).
5
 Another important conceptual issue to bear in mind is that QoL and 
HRQoL fluctuate and vary over time.
8
  
    It is generally agreed that HRQoL is a multidimensional concept and that a number 
of aspects should be included in its measurement. A minimum of four aspects (physical 
functioning, emotional and psychological functioning, social functioning and 
disease/treatment-related symptoms) plus a global measure of health status have been 
suggested to be sufficient to cover for multifactoriality.
8,9
 Dimensions that are relevant 
to include may vary between studies, and depend on which aspects are affected by 
disease or treatment for disease. Also, indirect consequences of disease, such as 
unemployment or financial difficulties, may be included.
5
 
     In this thesis a description of HRQoL after stroke by de Haan et al.
10,11
 has been 
used, including the following dimensions: psychological, physical, functional and 
social health. The psychological dimension comprises cognitive function, emotional 
status and general perceptions of health. Physical health refers to disease-related and 
treatment-related symptoms, and functional health has to do with self-care, mobility 
and physical activity level. The social dimension refers to social contacts and 
interactions. The results related to HRQoL in this thesis are presented within all of 
these dimensions. 
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2.2.1  HRQoL measurements 
HRQoL measures are classified into three types; generic health indices and profiles, 
specific measures (such as disease, population) and preference measures.
4
 Generic 
instruments are intended for general use and are often also applicable to healthy people, 
while specific measures focus on the particular concerns to a specific population or 
patients with a specific disease.
5
 
     Preference is an expression of which option of action a person might prefer in a 
situation after informed deliberation of the risks and benefits.
4,12,13
 There are some 
important differences between health state preferences and generic or specific HRQoL 
measures; generic and specific measures focus on identifying presence/absence, 
frequency, severity, duration of specific symptoms, or disabilities or impairments, 
whereas preference measures assesses individuals‟ preferences for health states or 
outcomes. Preferences measures provide an overall measure of HRQoL in which the 
respondent response combines the positive and negative dimensions of a specific health 
state into a single number that reflects the net effect of positive and negative aspects as 
perceived by the respondent. Contrary to specific HRQoL measures, preference 
measures provide a common unit of analysis that allows comparisons between different 
programs on the same scale.
4
 
     Measured preferences may be ordinal or cardinal; ordinal preferences are simply 
rank ordered from most to least preferred. Cardinal (or fundamental) preferences have a 
number on an interval scale that represents the strength of the preference of the 
outcome, relative to other preferences.
13
 Cardinal preferences are typically measured on 
a scale between 1 and 0, where 1 represents perfect health, and 0 is death, 
4,13,14
 but 
since some health states may be regarded as worse than death, negative values should 
be allowed.
15
  
 
2.3 ANEURYSM ETIOLOGY, PREVALENCE AND INCIDENCE 
An intracranial aneurysm is an abnormal dilatation of the vascular lumen of a cerebral 
artery and occurs most frequently in arterial bifurcations.
16
 The exact etiology is still 
unclear.
17
 It has been hypothesized that a congenital defect, a weak spot, in the muscle 
layer of the arterial wall allows the inner layers to bulge out and form an aneurysm. But 
since defect muscle layers in cerebral arteries also occur in people without aneurysms, 
it is believed that the pathogenesis include both congenital and acquired factors, such as 
hemodynamics, altered structures in cerebral arteries, genetics, trauma, infections and 
inflammation.
16,17
 In up to 30% of all patients with intracranial aneurysms, more than 
   5 
 
one aneurysm is present,
18
 a state which is defined as „multiple aneurysms‟. Within the 
subgroup of patients with multiple aneurysms about one-third has mirror aneurysms 
(two different aneurysms located bilaterally on corresponding arteries).
19
 
     The prevalence of harboring an intracranial aneurysm varies between autopsy 
studies and angiography studies,
20
 with estimates ranging from 0.2% to 9.9% with a 
mean of approximately 5%.
21
  
 
Intracranial aneurysms are most commonly asymptomatic before they rupture and 
cause a subarachnoid hemorrhage (SAH), which is also known as a hemorrhagic stroke, 
and accounts for up to 7.0% of all strokes.
22
 
     The ISUIA investigated the risk of rupture in patients harboring an intracranial 
aneurysm. In patients with no previous history of SAH, the risk of rupture depends on 
aneurysm size and aneurysm location. The cumulative rupture rate in patients with 
aneurysms less than 10mm in diameter was about 0.05% per year, and in patients with 
aneurysms a diameter of ≥ 10mm the rupture rate was 20 times higher.21 The relative 
risk for rupture in aneurysms < 10mm in diameter is 11.6 times lower than in 
aneurysms 10-24 mm in diameter, and 59.0 times lower than giant aneurysms (≥ 25mm 
in diameter). The relative risk for rupture was highest for aneurysms located at the 
basilar tip (13.8), and aneurysms in the vertebrobasilar arteries or posterior cerebral 
artery (13.6), when compared with other locations.
21
 
 
SAH incidence varies widely round the world, depending on geographical region, 
23,24
 
gender, 
25,26
 and ethnicity.
27-29
 Overall, the SAH incidence is higher in women, but 
differs between ages; men are predominant in the first three decades of life, then the 
incidence is equal by the fifth decade, and thereafter women predominate the 
incidence.
16
 A 2.1 times higher SAH incidence has been found in black people 
compared to whites.
30
 In a meta-analysis by de Rooij et al.
23
, an overall SAH incidence 
of 9.1/100 000 person-years was calculated. A large multinational study including 
populations from Europe and China found a ten-fold variation of the  annual incidence 
of SAH between countries; from 2.0/100 000 in China to 22.5/100 000 in Finland.
24
 In 
Japan the incidence of SAH is one of the highest in the world, 23.0/100 000.
31
 Since 
Swedish SAH patients not are included in the Swedish stroke register, Riks-Stroke, 
32
 
previous epidemiological studies on Swedish samples are regional; covering northern 
Sweden, 
24,33
 southern Sweden
34,35
 and Örebro. 
36
 To our knowledge only one study has 
investigated national incidence variations in Sweden and found an overall incidence of 
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12.4/100 000 person-years, increasing by latitude from 11.4 in the south to 15.2 in the 
north, and incidence was higher for women (14.4/100 000) than for men (10.3/100 
000).
37
 In the aforementioned Swedish studies, all diagnoses of SAH were included. 
However, SAHs could have causes other than ruptured aneurysms as the percentage of 
SAHs originating from ruptured aneurysms varies between >75% to >90% among 
SAH studies.
38
 A specified aneurysmal SAH incidence of 5.5/100 000 person years has 
been reported in Uppsala, a catchment area north of Stockholm.
39
  
 
2.4 RISK FACTORS FOR DEVELOPING ANEURYSMS AND SAH 
Familial aneurysms 
Several studies have reported that relatives of intracranial aneurysm patients have an 
increased risk in the development, growth and rupture of aneurysms, a phenomenon 
which is called „familial aneurysms‟. 38,40-43  A two-to-four times higher prevalence of 
intracranial aneurysms have been found in symptom-free first-degree relatives 
compared to the general population, 
41
 and the risk strongly increases in cases where 
there are two or more affected first-degree relatives.
42,43
 
 
Hormonal factors 
The predominance of aneurysmal SAH in women starts at age 55 and increases 
thereafter,
23
 leading to suggestions that female sex hormones may play a role in the 
pathogenesis of intracranial aneurysms.
44
 Female sex hormones and their relation to 
SAH have been studied as both endogenous  and exogenous factors, but the results are 
ambiguous; Johnston et al.
45
 reported that high-estrogen oral contraceptives produced a 
small increased risk for SAH, but, in contrast, other studies have found  that oral 
contraceptives do not affect the risk of SAH.
46-48
 The use of postmenopausal hormone 
replacement therapy have been reported to reduce the risk of SAH.
46,47,49
 Pregnancies 
have been reported to have a protective effect on the risk of SAH
47,50
 and others have 
found that the risk of SAH mortality decreases in women who have experienced more 
than one pregnancy.
51
 Mhurchu et al.
47
 reported a declined risk of SAH with older 
maternal age at first birth, but conversely, Yang et al.
51
 found an increased risk of 8% 
for SAH mortality for each year of the mother‟s age at first birth. 
 
Hypertension, smoking and alcohol 
The most important risk factors for SAH are smoking, hypertension, 
52,53
 and excessive 
alcohol consumption.
46,48
 Feigin et al.
46
 found that hypertension increased the risk of 
   7 
 
SAH by 2.5 times. Smoking women had a two-fold risk of SAH compared to smoking 
men, and excessive alcohol consumption had a more hazardous effect in women. 
 
2.5 FEATURES OF ANEURYSM RUPTURE 
SAH occurs at a younger age than ischemic strokes,
54
 as a large multinational study 
demonstrated, where a total target population of more than 3.8 million people showed 
an average age of 49.0 (±10.0) years at onset of SAH.
24
 The mean age at onset of stroke 
for other stroke types in Sweden is above 70 years.
55
 
     The circumstances surrounding intracranial aneurysm ruptures have been studied 
and results showed that aneurysms ruptured during stressful events (physical exertion 
or emotional strain) in 42.8% of cases. On the other hand, in 34.4% of cases, aneurysms 
ruptured during non-stressful activities, and for 11.8% of cases, during sleep.
56
 
Significant differences in the diurnal variation of onset aneurysm ruptures have been 
found, with an initial peak of incidence between 8:00 and 10:00 a.m., and a second 
peak between 6:00 and 10.00 p.m. Ruptures are less likely to occur between 10.00 p.m. 
and 6:00 a.m. No significant seasonal variation has been found.
31
  
     The three most common aneurysm locations are within in the anterior circulation of 
the circle of Willis: 30% in the region of the anterior communicating artery (ACoA), 
25% in the region of the posterior communicating artery (PCoA) and 14% in the region 
of the middle cerebral artery (MCA).
16
 Only 5-15 % of aneurysms are located in the 
posterior circulation (vertebral and basilar arteries).
16,57
 Figure 1 shows a schematic 
overview of the arteries in the circle of Willis. 
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Anterior circulation 
Internal Carotid Artery (ICA) 
Anterior Cerebral Artery (ACA) segment A1 
Anterior Cerebral Artery (ACA) segment A2 (Pericallosa) 
    Anterior Communicating Artery (ACoA) 
Middle Cerebral Artery (MCA) 
    Ophthalmic Artery (OA) 
Anterior Choroid Artery (AChA) 
Posterior Communicating Artery (PCoA) 
 
Posterior circulation 
Vertebral Artery 
Basilar Artery 
Posterior Cerebral Artery (PCA) segment P1 
Posterior Cerebral Artery (PCA) segment P2 
Superior Cerebellar Artery (SCbA) 
Anterior Inferior Cerebellar Artery (AICA) 
Posterior Inferior Cerebellar Artery (PICA) 
 
Figure 1. Arteries in the circle of Willis 
 
Clinical presentation of aneurysm rupture 
When an intracranial aneurysm ruptures, blood leaks into the subarachnoid space and 
causes a SAH, classically characterized by explosive onset of severe headache, 
decreased level of consciousness, nuchal rigidity and vomiting.
58
 Depending on the 
volume and the location of the bleeding, the aneurysm rupture may also produce 
hematomas; subdural, intracisternal, intracerebral, intraventricular, or a combination of 
   9 
 
these.
16,59
 During the rupture the intracranial pressure rises to diastolic blood pressure, 
and cerebral blood flow only occurs during the systolic phase. When the initial bleeding 
is not fatal, it is believed that the bleeding stops by a combination of coagulation and 
tamponade.
16
 Symptoms of aneurysm rupture range from mild, transient headache to 
deep coma with failing vital signs. When there is a hemorrhage into the brain, or into 
the cranial nerves, or when the regional blood flow is diminished in important areas of 
the brain, focal neurological deficits accompany the symptoms.
58
  
     A commonly used scale for clinical assessment of the patient‟s level of 
consciousness is the Glasgow Coma Scale (GCS). In the GCS, three aspects of 
behavior are evaluated and summed; motor responsiveness, verbal performance and eye 
opening. The GCS values range from 3 to 15.
60
  
     For assessment of the patient‟s neurological grade, the Hunt and Hess classification 
(H&H) of SAH
61
 is commonly used. H&H classifies the clinical condition into five 
grades, as follows:  
I:  Asymptomatic, or minimal headache and nuchal rigidity,  
II:  Moderate to severe headache, nuchal rigidity, no neurological deficits (except for 
cranial nerve palsies that may be present),  
III:  Confusion and drowsiness or mild focal deficits,  
IV:  Stupor, moderate to severe hemiparesis, possible early decerebrate rigidity and 
vegetative disturbances, 
V:  Deep coma, moribund appearance, decerebrate rigidity.
61
 
 
Natural history without aneurysm occlusion 
The prognosis of surviving patients depends on the severity of the initial bleed, the 
occurrence of complications and how successful the treatment to secure the aneurysm 
is.
62
 The complications include both intracranial complications (such as recurrent 
bleeding, hydrocephalus, vasospasm), and systemic complications (such as fever, 
hyperglychaemia, hypertension/hypotension, pneumonia, hyponatremia, myocardial 
ischemia).
62
 In an early study on hospitalized aneurysmal SAH patients with untreated 
aneurysms, recurrent hemorrhage occurred in 10% of cases during the first week, in 
12% the second week, in 7% the third week, in 8% the fourth week, and in 14% of 
cases in weeks 5-12 after the onset.
63
 Winn et al.
64
 followed-up aneurysmal SAH 
patients with untreated aneurysms for up to 20 years, and reported a re-bleed rate 
average of at least 3% per year. The rate of fatal re-bleeds were 2% per year during the 
first decade.  
 10 
 
2.6 MANAGEMENT OF ANEURYSMAL SAH   
Before aneurysm securement 
In the acute care after aneurysmal SAH, multidisciplinary collaboration between 
neurosurgeons, neuroradiologists, neurointensivists and specialist nurses is essential.
62
 
In Sweden all incidents of SAH are referred for treatment at intensive care units. 
Further medical investigations and aneurysm treatments are performed at neurosurgical 
departments.
65
 During the intensive care period, highly advanced technological care is 
performed, including: continuous observations of neurological functions and vital 
parameters; detection and treatment of cerebral vasospasm;  intracranial pressure 
monitoring; pain assessment and treatment; prevention of vein thrombosis and 
pulmonary embolism; pressure sore prophylaxis; and pharmaceutical 
administration.
62,66-69
 At hospital admission most patients are too ill to assimilate 
information, thus during this first stage information is instead given to family 
members.
69
 
 
Aneurysm occlusion 
The treatment goal for ruptured intracranial aneurysms is to prevent re-bleeding by 
completely and permanently occluding the aneurysm thus excluding it from the 
cerebral circulation while preserving the blood flow in the parent artery and perforating 
vessels. The choice of therapy depends on factors such as the patient‟s age and 
condition, aneurysm location, aneurysm characteristics, and the occurrence of 
intracerebral hematoma. The two most common treatment alternatives are 
microsurgical clipping and endovascular coiling.
70
 Surgical clipping is performed via a 
craniotomy, when a stable metal clip is placed across the neck of the aneurysm.
71
 
Endovascular coiling excludes the aneurysm from the circulation by embolization with 
detachable coils, filling the aneurysm sac.
70
 Rapid advances in the 1990s in 
endovascular technology and techniques have led to an increasing number of 
aneurysms being treated with coiling
72
 and have also decreased the proportion of earlier 
untreatable aneurysms.
73,74
 Nowadays, assisting techniques could be used when the 
aneurysm neck is wide, such as deploying a stent over the aneurysm neck or balloon 
remodeling before coiling.
70,75
 A small proportion of aneurysms are considered unable 
to be completely excluded from circulation by the usual methods; some of them can be 
treated by wrapping cotton, muslin, or adhesive material or muscle round the aneurysm, 
and sometimes the wrapping material is secured with a clip ligation.
76,77
 Complex 
aneurysms can be treated with bypass surgery followed by trapping the parent artery. 
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Bypass surgery could be performed extracranial-intracranial or intracranial-
intracranial.
78,79
 The timing of treatment is most often divided as follows: early 
treatment within 0-3 days from rupture; intermediate treatment 4-7 days after rupture; 
and late treatment more than 7 days after rupture. It has been suggested that early and 
intermediate treatment improves outcomes after aneurysm rupture.
80
 Benefits of early 
treatment are a reduction of risk of a re-bleed and safer prevention/treatment of cerebral 
vasospasm.
81
 
      
After aneurysm securement 
When the aneurysm is secured the care is continued at the intensive care unit with some 
adjustments: if the patient remains stable, neurological and vital parameter assessments 
are decreased and the patient‟s motor activity is gradually increased.69 When the health 
condition has stabilized and the risk of cerebral vasospasm is low, the patient is 
transferred to a neurosurgical ward. Vital signs and neurological assessments should be 
performed every 4-8 hours and medications are to be maintained. Activity is further 
increased as tolerated by the patient. Physical and occupational therapy may be 
consulted for assessment of patient functioning and needs for rehabilitation.
69
 
     A commonly used scale to assess neurological outcome at hospital discharge is the 
Glasgow Outcome Scale (GOS), as recommended by the World Federation of 
Neurosurgical Societies in the assessment of outcomes after SAH.
82
 
 
Table 1. Glasgow Outcome Scale
83
 
Category Description 
1 Death 
2 Persistent vegetative state 
3 Severe disability, conscious but disabled, dependent on daily support 
4 Moderate disability, disabled but independent 
5 Good recovery, resumption of normal life although there may be minor deficits 
 
After hospital discharge - rehabilitation  
Effective rehabilitation requires multidisciplinary competence with experience of, and 
specialization in stroke care, from physicians, nurses, physiotherapists, occupational 
therapists and speech therapists. During rehabilitation, multidisciplinary interventions 
follow national guidelines and are usually specific and task-oriented, but should also be 
in accordance with the patient‟s own goals.84 
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     The National Swedish Board of Health and Welfare recommends ensuring access to 
rehabilitation during the first post-stroke year,
65
 but all aneurysmal SAH patients do not 
receive rehabilitation.  
 
Follow-up and support 
The follow-up of ischemic stroke patients after rehabilitation varies widely; from 
nothing at all, to outpatient therapy.
85
 Kirkevold
85
 describes the discharge from the 
rehabilitation unit as a transition into a new phase – patients struggle to return to their 
former life, they re-think who they are, what their priorities are, and emotionally 
processes losses – which could be considered a kind a grief work. Most of this 
adjustment process occurs after discharge from the stroke rehabilitation unit.  
     The Helsingborg Declaration 2006 on European Stroke Strategies is a statement of 
the overall aims and goals of stroke management in European countries to be achieved 
by 2015. The stated goal for the evaluation of stroke outcome and quality assessment is 
that all countries should have a system for the routine collection of data needed to 
evaluate the quality of stroke management.
84
 One of the core indicators for assessment 
of quality of care is population-based monitoring of the incidence of stroke as well as 
case fatality.
84
 In Sweden the stroke care is monitored by the Swedish Stroke Register 
(Riks-Stroke). Established in 1994, it includes all 76 hospitals in Sweden that admit 
acute stroke patients. This register follows patient outcomes (such as functional ability, 
perceived health, QoL and mood), quality of care and community support three months 
and one year after the stroke event. However, patients with the stroke type SAH are not 
eligible to be included in this register and, to date, the Riks-Stroke has not attempted to 
involve neurosurgery services in the collection of data.
32
 Because there is no existing 
national SAH register, some epidemiological data are lacking for these patients. It is 
also unknown how aneurysmal SAH patients perceive quality of care or support.  
      
2.7 MORTALITY AND DEATH CAUSES 
The overall risk of death before receiving medical attention for aneurysmal SAH has in 
a meta-analysis been calculated to be 12.4% of cases.
86
 Ruptured aneurysms in the 
posterior circulation of the brain are associated with a higher risk of death before 
hospital admission.
86
 
     A multicenter study on SAH epidemiology in 11 populations from Europe and 
China showed that the 28-day case fatality ranged from 23% to 62%, with a mean of 
42%.
24
 In a meta-analysis including 39 studies from Asia, Australia, New Zealand, 
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North America, South America and the Caribbean, the case fatality ranged 8.3 – 66.7%. 
In Finland and north Sweden the case fatality was found to be 44.4%. A Swedish study 
on SAH epidemiology from the Swedish hospital discharge and Cause of death 
registries showed a 28-day case fatality of 31.7%.
37
 However, none of these studies 
distinguished aneurysmal SAH from other types of SAH, and SAH cases of non-
aneurysmal origin have generally a better prognosis.
37
 Information on the case fatality 
after aneurysmal SAH in Sweden is therefore insufficient. 
     The major causes of death the first month after aneurysmal SAH are the initial and 
recurrent bleeding.
87
 In the International Subarachnoid Aneurysm Trial (ISAT) the 
most common death cause during the first year after the aneurysm rupture was 
complications of severe dependent survival (such as infections).
88
 After the first year of 
the onset of aneurysmal SAH, the majority of deaths are cardiac-related or due to 
malignancies.
88-90
 
 
2.8 SURVIVING ANEURYSMAL SAH AND LIVING WITH THE 
CONSEQUENCES 
Survivors of aneurysmal SAH differ from other stroke survivors; the proportion of 
women is higher and the mean age at onset is approximately 20 years younger 
compared to other stroke types.
24,55
 This younger mean age implies that SAH, to a 
larger extent, strikes people who are in their prime working years and thus they are 
likely to be responsible for young children. 
 
Physical consequences 
Well-known functional impairments after both ischemic and hemorrhagic strokes 
include motor impairments, sensory deficits, visual deficits, and speech and language 
disorders.
91
 Motor impairments can affect movements of the face, arms and legs, which 
affect an individual‟s ability to perform activities of daily living.92 Meta-analyses have 
been conducted to evaluate the percentage of patients being disabled following 
intracranial aneurysm rupture; for example, Hop et al.
93
 analyzed disabilities 1-48 
months after the onset and found that on average, 10-20% of survivors of aneurysmal 
SAH become so disabled that they lose their independence and have to rely on others to 
carry on in their daily lives. In the meta-analysis by Nieuwkamp et al.,
94
 55% of 
patients remained independent and 19% were dependent on help for activities of daily 
living 1-12 months after the onset. Carter et al.
95
 followed 182 patients from 1-6 years 
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after SAH and found conflicting results: 76.2% had no disabilities, and only 3% were 
severely physically disabled.  
     About 20% of patients experience one or more epilepsy seizures after aneurysmal 
SAH, and most frequently the seizures are not recurrent.
96
 Late epilepsy is, in the vast 
majority of patients, manifested within two years after the SAH. Epilepsy could be 
caused by the SAH itself, aneurysm treatment, or both.
96
 The risk of epilepsy has been 
found to be significantly higher in patients treated with clipping. The suggested 
explanation for this is that during surgical procedures, disturbances of the cortical 
surface occur, due to dissection and retraction.
97
 Other predictors that increase the risk 
of epilepsy have been found to be younger age,
96,97
 a large amount of subarachnoid 
blood on CT scan, vasospasm, thromboembolic complications and MCA aneurysm 
location.
97
 Epilepsy has a significant impact on individual patients and their families‟ 
lives due to driving prohibition, and having the condition may also affect their 
employment status.
97
  
     Hydrocephalus (HC) is a common sequel to aneurysmal SAH. In general, post-
hemorrhagic HC is caused by obstructive mechanisms due to blood or adhesions 
blocking the cerebrospinal fluid circulation within ventricles and cisterns.
98
 HC after 
SAH could be developed acutely or insidiously over weeks or months and could be 
classified into three temporal stages; acute (0-3 days after SAH), sub-acute (4-13 days 
after SAH) and chronic (≥ 14 days after SAH).99 Acute HC may resolve spontaneously, 
but in 18-20% of aneurysmal SAH patients chronic HC develops and a permanent 
cerebrospinal fluid shunt implantation is needed.
98-100
 The risk of chronic HC has been 
found to be lower in patients treated with clipping, and the suggested explanation is that 
open surgery affords the opportunity to open cerebral cisterns and remove the clot and 
blood.
98
 Chronic HC after aneurysmal SAH has been found to decrease physical 
HRQoL.
101
  
     Another problem that impacts upon the patients‟ lives is post-stroke fatigue, an 
overwhelming feeling of exhaustion that leads to the difficulty or inability to sustain 
even routine activities.
102,103
 Staub & Bogousslavsky
103
 argue that post-stroke fatigue is 
not a component of post-stroke depression, and that these two conditions develop 
independently of each other. Post-stroke sleep-wake disorders (SWD) may play a role 
in subjective fatigue because they may cause somnolence and fatigue.
103
 SWD have 
previously been reported in 34-47% of cases 1-7 years after SAH.
104-106
 Fatigue was 
reported by 17% of patients nearly nine years following aneurysmal SAH.
107
 Stroke-
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related features, such as location of stroke lesion and severity of neurological 
impairment, do not seem to play a role in post-stroke fatigue.
103
 
 
Psychological consequences 
Anxiety and depression after ischemic stroke is a well-known problem and it has been 
debated in the literature whether it is a reaction to the onset of disability and life 
changes, or if it is an organic result of biochemical changes from neurological 
damage.
108,109
  Berry et al.
110
 suggested several factors that may contribute to 
psychological distress in patients after aneurysmal SAH; a recent life threatening 
experience, fear of recurrent hemorrhages, anxiety over symptoms, lack of 
understanding of cognitive difficulties and changes in social roles.  
     Post-stroke depression is defined as a prominent and persistent mood disturbance, 
characterized by depressed mood, or lack of interest, or lack of pleasure in all or almost 
all activities.
111
 Post-stroke depression prevalence ranges between 5 and 67% after all 
types of strokes. After two years, 18-55% (with a mean prevalence of 33%) of stroke 
survivors are depressed.
112
 Depression after aneurysm rupture has been assessed at 
different time points. Studies have reported depression in 23-28% of cases 21-36 
months after rupture; 
113,114
 Carter et al.
95
 reported that 36.3% of respondents scored 
depression to some extent, and 23% scored for severe mood disturbances 1-6 years 
after the onset. Lindberg
115
 followed-up respondents in mean seven years after SAH, 
and reported that 22% of respondents were depressed. Bellebaum et al.
116
 reported that 
patients treated with clipping scored with significantly more depressive symptoms than 
coiled patients. 
     Visser-Meily et al.
114
 reported anxiety symptoms in 32% of aneurysmal SAH 
patients 2-4 years after the rupture. Nearly nine years after aneurysmal SAH, Wermer 
et al.
107
 reported 11% of patients scoring with anxiety symptoms. 
     Disorders of emotional expression control, also called emotional lability or 
emotionalism, is common after strokes in general, and is described as the lack of 
voluntary control of the expressions of crying, laughter, or both.
112
 Emotionalism is an 
increase of the frequency of crying or laughing, that starts unexpectedly or with little 
warning.
117
 It can be precipitated by nonspecific or inappropriate stimuli, or by an 
appropriate stimuli in an inappropriate context.
112
 
 
Cognitive function after SAH has been assessed in several studies at different time 
points following aneurysm treatment, and assessments areas are both global cognition 
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and specific domains such as memory, perception and executive functions. Executive 
functions are the mental resources needed to control sequences of thoughts and the 
actions that are needed for planning, organizing, setting goals, follow-through activities 
and problem solving.
118
 
     Both Mayer et al.
119
 and Hillis et al.
120
 conducted cognitive testing in patients 3 
months after aneurysmal SAH. Mayer et al.
119
  found impairments in visual and verbal 
memory, reaction time, motor function, executive function, visuospatial function and 
language function, and Hillis et al.
120
 found significant lower performance in memory 
tests. Significantly lower scores on memory tests were also found in SAH patients eight 
months after aneurysm rupture when compared to matched controls.
110
 Sonesson et 
al.
121
 reported that only 17.2% of patients with satisfactory neurological recoveries 
were cognitively unaffected or had very mild dysfunctions in mean 56 months after 
aneurysm rupture. Hütter and Gilsbach
122
 followed aneurysm patients with good 
neurological outcome with cognitive tests 1-5 years after rupture and found that 54% of 
patients were substantially impaired in some aspects of cognitive capacity. Older 
patients had significantly worse cognitive problems than younger patients. Ogden et 
al.
105
 followed patients 4-7 years after rupture and found that subjective memory 
difficulties were reported by 45.3% of patients. In a study on cognition five years after 
SAH in general, SAH patients performed significantly worse on all language- and 
information-processing speed tests when compared to matched controls.
123
 
     It has been proposed in the literature that aneurysm location may influence cognitive 
outcome, but the results are inconsistent. Both Tidswell et al.
124
 and Stenhouse et al.
125
 
addressed cognitive function after aneurysm rupture in the ACoA, and found that 
patients with such aneurysms were not significantly more cognitively impaired 
compared to other aneurysm locations, however, the majority of patients in these 
studies, 65% and 59% respectively, did indicate cognitive problems. Hütter et al.
126
 
found that patients with ruptured left-sided MCA aneurysms had significantly more 
problems in cognition and communication compared to right-sided ones. They also 
found that aneurysms presenting with additional intraventricular hemorrhage had 
significantly more problems in cognition. In contrast, Haug et al.
127
 found somewhat 
better cognitive performance for patients with MCA aneurysms compared to patients 
with ACoA aneurysms, attributed to the fact that a SAH from an ACoA aneurysm 
affects the medial part of the frontal lobes. In other studies, the aneurysm site has not 
shown any relation to cognitive outcome.
128
 When cognition has been assessed in 
relation to treatment variables, results have shown no significant differences in 
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cognition when comparing treatment modalities, 
128
 or between late versus early 
aneurysm obliteration.
121
  
 
It is well known that stroke may produce persistent personality disturbances, defined as 
a change from the previous characteristic personality, including labile, disinhibited, 
aggressive, apathetic, and paranoid types.
112
 In an early study by Storey,
129
 personality 
changes after SAH were assessed, mostly from the statements of close relatives, in 261 
patients nearly three years after the onset. The results showed impaired personality in 
41%, and improved personality in 5% of cases. Several changes in personality were 
described, such as more irritable, emotionally labile, withdrawn, selfish and suspicious. 
Ogden et al.
105
 reported subjective experienced personality changes in 48.3% of cases 
in a sample of SAH patients 4-7 years after the onset. Examples of reported subjective 
changes in their study were that they were more irritable, had lowered self-confidence 
and increased emotionality. Wermer et al.
107
 followed-up SAH patients nearly nine 
years after the onset and 59% of cases reported subjective personality changes, of 
which 13% reported positive personality changes. The most common changes were 
increased agitation, apathy and increased emotionality. 
 
Social consequences 
Daniel et al.
130
 reviewed studies reporting social consequences of stroke (all stroke 
types) for working-aged adults. Slightly more than half of the patients who worked 
before the stroke had returned to paid employment 6-12 months after the onset. In 
studies quantifying social or leisure activities, a decrease of 15-79% was reported. In 
studies reporting consequences for family relationships, 5-54% of samples experienced 
family problems. Described effects for children of the patients included conflicts and an 
impact on caregiving. Deterioration in sexual relationships ranged from 5-76%.
130
 
 
There are few studies reporting social consequences after aneurysmal SAH, and the 
findings in these studies are similar to those of Daniel et al.
130
 Among patients returned 
to work, a large proportion report not being able to return to the previous level of 
employment, with shorter working hours and less responsibility.
105,107,131
  
     The burden on relatives and family strain after aneurysmal SAH has also been 
reported. Mezue et al.
132
 describe that there is often a „honeymoon period‟ after the 
patient‟s discharge, cushioned by the relatives‟ high expectations of recovery. 
However, as time passes, the reality of the permanence of the condition becomes 
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apparent and the significant others may not be able to cope with all of the changes that 
impact on their own lives. Pritchard et al.
133
 depict these difficulties as dysfunctional 
stress on caregivers; that it was easier to deal with the initial crisis at the onset SAH 
than coping with the patient after they had returned home. The caregivers also 
described that their employment was affected.
133
 Affected intimate relations due to a 
loss of libido has been reported,
131
 and nearly nine years after aneurysmal SAH, 7% of 
respondents were divorced as a direct result of the consequences of the SAH.
107
 
 
Dealing with changes  
When experiencing a dramatic change in health status, such as a life-threatening 
disease, one‟s footing in life may be lost. The impact may be so complex that it intrudes 
on every aspect of the patient‟s reality; the previous reality does not exist and a new 
one has not yet been constructed. This alteration results in a period of uncertainty – a 
transition to something new.
134
 Transition could be described as a period of instability; 
a passage from a fairly stable life phase, state or condition to another.
135
 People do not 
experience transitions uniformly, even when the circumstances are similar. The 
meaning that the individual constructs out of an experience of transition depends on 
several dimensions, such as: duration, scope, reversibility, anticipation and 
voluntariness.
135
 Different types of transitions have been identified: health/illness 
transitions could be caused by alterations in health status, such as moving from 
wellness to acute or chronic illness, or by moving between different levels in the health 
care system over the course of an illness. Situational transitions occur by a change of 
position or circumstance, for example, changes in family situations, in professional 
roles, or a near-death experience.
136
 Transition implies adaptation to change, not to 
return to a pre-existing state.
137
 Most transitions involve critical turning points or 
trigger points that are associated with an increased awareness of changed reality, its 
consequences and the permanency of the alteration.
134,139
 These periods are associated 
with heightened vulnerability.
139
 Two such trigger points have been identified during 
the first year after ischemic stroke; at discharge from rehabilitation clinic, and when 
returning to work or other meaningful activities outside their close social network, with 
increased needs at each point for consolation, emotional encouragement and help to 
interpret future possibilities and limitations.
85
 Transitional experiences after aneurysmal 
SAH have not been described in the literature. 
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3 THESIS RATIONALE 
 
Patients suffering from intracranial aneurysm rupture differ from ischemic stroke 
patients in some important aspects: they are younger at the onset, women are 
predominant and they are treated at neurosurgical clinics. Furthermore, they are not 
included in the Riks-Stroke register, and there is no national SAH register, thus existing 
epidemiological data are insufficient.  
 
Although numerous studies on clinical outcomes after aneurysmal SAH have been 
conducted, there are still unexplored areas related to its long-term impact on life. 
Previous studies have looked at aspects of HRQoL in patients after intracranial 
aneurysm rupture but these are most frequently conducted during the first 18 months 
after the onset of aneurysm rupture. Most commonly, a cross-sectional design is used, 
and there are few studies that follow aneurysmal SAH patients longitudinally to detect 
changes over time. Long-term studies, with follow-up more than five years after the 
rupture, are scarce. Knowledge on the long term perceived consequences patients are 
suffering from after intracranial aneurysm rupture is therefore limited.  
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4 AIMS 
 
The overall aim of the studies in this thesis was to describe impact on life up to ten 
years after intracranial aneurysm rupture in terms of health-related quality of life, 
changes in everyday life and descriptive epidemiology. This thesis is based on four 
papers with the following specific aims: 
 
I. To describe changes and transitions in everyday life the first two years 
following an intracranial aneurysm rupture. 
 
II. To describe epidemiology in relation to gender differences and treatment 
modalities ten years after intracranial aneurysm rupture. 
 
III. To describe psychological, physical and cognitive functions ten years after 
intracranial aneurysm rupture, and to identify any differences in outcome 
variables between age-groups, gender or aneurysm locations. 
 
IV. To measure HRQoL and to explore factors affecting HRQoL, ten years after 
aneurysmal subarachnoid hemorrhage.  
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5 MATERIAL AND METHODS 
5.1 DESIGN 
This thesis includes observational studies with different designs and approaches, 
depending on the purpose of the study. Table 2 shows an overview of the used designs 
in the papers included in this thesis. 
 
Table 2. Overview of designs 
Paper Design Approach Type of data Time-frame from 
aneurysm rupture 
I Prospective 
longitudinal 
Mixed method Self-reported 
outcomes 
6 months, 1 year, 
2 years 
II Retrospective 
cohort 
Quantitative Register data 10 years 
III Cross-sectional Quantitative Self-reported 
outcomes 
10 years 
IV Retrospective 
cohort 
Quantitative Self-reported 
outcomes 
10 years 
 
5.2 SETTING AND SAMPLES 
In this thesis project, two data collections were conducted. Patients in both data 
collections were recruited from a Swedish neurosurgical clinic in Stockholm County, 
covering approximately 2 million inhabitants. All patients in the aneurysm samples 
were acute admissions; patients treated for non-ruptured aneurysms were not included. 
The number of admitted patients with ruptured intracranial aneurysms at the clinic is 
about 100 per year. The clinic uses a clinical pathway protocol for ruptured aneurysms, 
including earliest possible aneurysm occlusion and aggressive anti-vasospasm 
treatment.
140
 A return visit, with the possibility to meet the neurosurgeon or radiologist 
who conducted the aneurysm occlusion, is performed about three months after the 
rupture. Radiological follow-up is performed and is largely the same regardless of 
whether the patient was treated with open surgery or endovascularly. The only 
exception is that a conventional X-ray is also performed three months after the onset for 
endovascularly treated patients. Thereafter, all aneurysmal SAH patients are followed 
with angiograms at 1, 3, 5, 10 and 20 years after the onset.  
 
Paper I.  
Patients (n = 88) were prospectively consecutively recruited from 1
st
 of March 2006. 
Inclusion criteria were: Swedish citizen (to enable follow-up and assess patient 
records); a sufficient health condition allowing participation (i.e. Glasgow Outcome 
Scale >2 at hospital discharge); and able to communicate in Swedish. Patients were 
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identified from International Classification of Disease codes (ICD-10)
141
 in the 
hospital‟s statistics database of admitted patients (LISA), and from the neurosurgical 
clinic‟s intensive care unit SAH register. Figure 2 shows a flowchart of the sample in 
paper I. There were no significant differences between patients declining participation 
(n = 16) and those included in the study concerning rupture age, sex, aneurysm 
treatment, aneurysm locations, or GOS at hospital discharge. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Sample in paper I 
 
Paper II.  
Included patients (n = 468) were retrospectively identified through clinical registers 
based on ICD-9 and ICD-10 diagnoses. All consecutive cases of aneurysmal SAH from 
1 January 1996 to 31 December 1999 were eligible. The inclusion criteria were: 
Swedish citizenship, and living in Sweden for the ability to retrieve Swedish register 
data on survival and cause of death.  
 
 
 
Assessed for eligibility (n=151) 
 
Not meeting inclusion criteria: 
 Deceased (n=30) 
 Poor health (n=12) 
 Language (n=4) 
 Emigrated (n=1) 
 
Lost to follow-up:  
Non-responders (n=1) 
 
Analysis 
Returned questionnaire 6 
months after SAH, included 
 (n=88, 84.6% of eligible) 
 
Returned questionnaire 1 year 
after SAH (n=87) 
 
Returned questionnaire 2 years 
after SAH (n=84) 
 
Lost to follow-up:  
Non-responders (n=3) 
Deceased (n=1) 
 
Eligible (n=104) 
 
Declined to participate (n=6) 
Non-responders (n=10) 
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Papers III and IV 
Survivors from the sample in paper II were assessed for further follow-up in papers III 
and IV. Inclusion criteria were: a sufficient health condition allowing participation; able 
to communicate in Swedish; and Swedish citizenship for the ability to follow-up and 
assess patient records. From the eligible 273 patients, 79.5% (n = 217) were included in 
papers III and IV. There were no significant differences between patients declining 
participation (n = 56) and those included in the study concerning age, sex, aneurysm 
treatment, aneurysm locations, or GOS at hospital discharge. 
     In paper IV a comparison sample from general population (n = 434) derived from 
the Stockholm Public Health Survey 2006 was used. The Stockholm Public Health 
Survey was sent from Stockholm County Council to monitor population health, and 
was sent to a representative sample of 57 000 persons aged 18-84 years in Stockholm 
County, with a response rate of 61%. Each respondent in the aneurysm sample was 
matched by age and sex to two controls, randomly selected by the statistical program 
SPSS. Figure 3 shows a flowchart of samples in papers II to IV. Characteristics of 
respondents in papers I-IV is presented in table 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Aneurysm sample in papers II-IV 
 
Assessed for eligibility (n=477) 
 
Not meeting inclusion criteria: 
 Non-Swedish citizens (n=9) 
  
 
Included (n=468) 
Assessed for further follow-up, 
eligible (n=273) 
Returned questionnaires 10 
years after SAH, included 
(n=217, 79.5% of eligible) 
 
 Not meeting inclusion criteria: 
 Deceased (n=166) 
 Poor health (n=20) 
 Emigrated (n=5) 
 Language (n=4) 
 
Paper II 
Analysis 
Analysis 
Paper III Paper IV 
Declined to participate (n=23) 
Non-responders (n=33) 
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Table 3. Characteristics of respondents in papers I-IV 
 
Paper 
 
n 
Age 
(years) at 
onset 
Age (years) 
at follow-up  
Males / females H&H at 
admission 
Treatment: 
O/E/C 
GOS at 
discharge 
m (SD) m (SD) n (%) n (%) n         (%) n (%) 
I 88 52.6  (14.2)   30/58 
 
(34/66) I-III: 72  
 
IV-V: 16 
(82) 
 
(18) 
34/54/0 
 
(39/61/0) 
3: 14  
4: 24  
5: 50  
(16) 
(27) 
(57) 
II 468 54.9  (13.2)   139/329 
 
(30/70) I-III: 289 
 
IV-V: 
179 
 
(62) 
 
(38) 
325/67/76 
 
(70/14/16) 
1: 89  
2: 19  
3: 93  
4: 72  
5: 195 
(19) 
(4) 
(20) 
(15) 
(42) 
III 217 50.6  (12.0) 60.7  (12.0) 63/154 
 
(29/71) I-III: 174 
 
IV-V: 43 
 
(80) 
 
(20) 
181/35/1 
 
(83/16/1) 
2: 3  
3: 38  
4: 35  
5: 141  
(1) 
(18) 
(16) 
(65) 
IV 651:            
Aneurysm 
sample 
 
217 
 
 
 
50.6  
 
 
(12.0) 60.7  
 
 
(12.0) 
 
 
63/154 
 
 
(29/71) 
 
I-III: 174 
 
IV-V: 43 
(80) 
 
(20) 
181/35/1 
 
(83/16/1) 
 
2: 3  
3: 38  
4: 35  
5: 141 
(1) 
(18) 
(16) 
(65) 
Comparison 
sample 
434   60.7 (11.9) 126/308 (29/71)      
Treatment: O/E/C = open surgery/endovascular procedure/conservative 
H&H= Hunt and Hess classification of subarachnoid hemorrhages 
GOS = Glasgow Outcome Scale 
 
 
5.3 DATA COLLECTION 
Clinical data were collected from digital and paper patient records, epidemiological 
data were retrieved from the Swedish Cause of Death Register and county council 
statistics from Swedish Association of Local Authorities and Regions.
142
 Six 
instruments were used to assess different aspects of HRQoL. Used measurements, and 
clinical and diagnostic classifications are further described below. 
 
5.3.1 Measurements 
The used instruments, except for a study-specific questionnaire, were chosen on the 
basis of their previous use in studies on outcome assessment after ischemic stroke or in 
intracranial aneurysm populations. A short description of the used instruments, 
including validity and reliability testing, is given below. Table 4 presents an overview 
of used instruments and their relation to HRQoL domains described by de Haan et 
al.
10,11
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Table 4. HRQoL domains and aspects in relation to used instruments 
Domain described 
by de Haan et 
al.
10,11
 
HRQoL aspect Instrument Data collection 
method 
Paper 
Physical health Physical 
symptoms 
Study-specific Questionnaire I, III, IV 
Pain/discomfort EQ-5D 
descriptive 
system 
Questionnaire IV 
Functional health Activity of daily 
living, mobility 
Barthel Index Telephone 
interview 
III 
Mobility EQ-5D 
descriptive 
system 
Questionnaire IV 
Self-care EQ-5D 
descriptive 
system 
Questionnaire IV 
Psychological 
health 
State anxiety 
 
State Trait 
Anxiety Inventory 
Questionnaire III 
Anxiety/ 
depression 
Hospital Anxiety 
and Depression 
Scale 
Questionnaire III 
EQ-5D 
descriptive 
system 
Questionnaire IV 
Cognition Telephone 
Interview for 
Cognitive Status 
Telephone 
interview 
III 
Mood  
 
Study-specific Questionnaire I 
Personality 
 
Study-specific Questionnaire I 
Overall 
perception of 
health 
EQ-5Dindex 
 
Questionnaire IV 
EQ VAS 
 
Questionnaire IV 
Social health Housing 
conditions 
Study-specific Questionnaire I 
Working 
conditions 
Study-specific Questionnaire I 
Social activities 
 
Study-specific Questionnaire I 
Usual activities EQ-5D 
descriptive 
system 
Questionnaire IV 
 
State Trait Anxiety Inventory (STAI) is a measure of psychological status, and 
distinguishes between state and trait anxiety, measured on two different scales. State 
anxiety is a function of how an individual perceives stressors and how this fluctuates 
over time. Trait anxiety can be described as a relatively stable personal trait.
143
 The 
initial version of STAI measured both state and trait anxiety on the same scale, but has 
later been modified to measure state and trait anxiety on two different scales. In paper 
III the later form of STAI state anxiety
144
 was used. Construct validity of the STAI state 
has been evaluated in different groups and the results show higher mean values in 
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stressful situations than in non-stressful situations.
144
 In a review study on STAI 
reliability of 59 studies, mean value for test-retest reliability of STAI state was 0.70 and 
mean internal consistency was 0.91.
145
 The STAI state consists of 20 statements that 
encourage respondents to describe how they feel at a particular moment in time by 
rating on a four-point scale: not at all, somewhat, moderately and very much. The 
scores range from 20 to 80; higher scores indicate higher levels of anxiety. A cut-off 
score of 39 has been used to detect clinically significant symptoms of state anxiety.
146
 
STAI have previously been used in patients with ischemic stroke
147
 and intracranial 
aneurysms.
148,149
 
 
Hospital Anxiety and Depression Scale (HADS) is a 14-item measure for detecting 
states of anxiety and depression constructed by Zigmond and Snaith.
150
  The statements 
are divided into two subscales; one for anxiety (HADS-A) and one for depression 
(HADS-D). Each subscale score ranges from 0-21; higher scores indicate severe 
anxiety or depression disorders. Scores 8 on HADS-A or HADS-D are considered to 
indicate anxiety and depression respectively, and are the most frequently used cut-off 
scores for subscales, with a sensitivity and a specificity for both subscales of 
approximately 80%. 
151
 Scores of 8-10 identify mild cases; scores of 11-15 identify 
moderate cases, and scores 16 identify severe cases on HADS subscales.152,153 HADS 
could also be considered as a unidimensional scale of mental distress.
154
 Using total 
HADS, a cut-off score of ≥11 has been used on a aneurysmal SAH population, 114 with 
a sensitivity of 89%, and a specificity of 66%. 
155
 HADS has, in several studies, been 
proven to be a valid and reliable instrument for anxiety and depression in patients with 
both somatic and mental problems, 
151,155,156
 and in stroke patients.
157
 HADS has 
previously been used after aneurysmal SAH.
107,114,158,159
 
 
The Barthel Index (BI) is a scale constructed by Mahoney and Barthel 
160
 that describes 
mobility and activities of daily living (ADL) using ten variables (feeding, transfers, 
grooming, toilet use, bathing, walking, climbing stairs, dressing, controlling bowels and 
controlling bladder). The sum of the scores range from 0-100; a higher score is 
associated with a greater likelihood of being able to live independently at home.
160
 
Scores lower than 60 indicate severe disability, 61-79 moderate disability, 80-99 mild 
disability and 100 no disability. 
95,161
 BI has been shown be a valid and reliable measure 
of ADL after stroke,
162,163
 and also reliable when used in telephone interviews.
164
 BI 
has been used after aneurysmal SAH in several studies.
89,95,158,159,165-168
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Telephone Interview for Cognitive Status (TICS) was developed by Brant, Spencer and 
Folstein
169
 to enable easily accomplished and cost-effective screening of Alzheimer‟s 
disease patients. TICS has been shown to be a valid and reliable instrument to detect 
post-stroke dementia, 
170,171
 and has been used for cognitive assessment after 
aneurysmal SAH.
119,172,173
 The TICS is a structured 11-item interview that evaluates 
orientation (to person, time and place), attention (counting backwards 20-1 and serial 
sevens), verbal memory (recall of a 10-item list), long-term memory (naming Swedish 
Prime minister and Minister for finance is used in the Swedish version), motor function 
(finger tap) and language (naming, repetitions and antonyms). The maximum score is 
41 and the cut-off score <31 is used to predict cognitive impaired individuals.
169
 With 
the mentioned cut-off score, TICS has a sensitivity of 94%, and a specificity of 
100%.
169
 Other cut-off score have also been used; Desmond et al.
170
 used a cut-off of 
25 with a sensitivity of 100% and a specificity of 83%. Barber & Stott
171
 found that a 
cut-off score of 28 gave a sensitivity and specificity of 88% and 85% respectively.  
 
The EQ-5D is a generic HRQoL instrument developed by a consortium of 
investigators,
174,175
 and has been shown to be a valid and reliable measurement of 
HRQoL after stroke.
176-178
 EQ-5D has previously been used in intracranial aneurysm 
populations.
168,179,180
 The EQ-5D consists of two parts: (1) A descriptive system of 
health in five dimensions (mobility, self-care, usual activities, pain/discomfort, 
anxiety/depression), classified by the respondent within three levels (no problems, 
some problems and severe problems). In the mobility dimension the respondent reports 
the ability to walk about. The usual activities dimension is a social dimension and refers 
to work, study, housework, family or leisure activities. In the dimension self-care, the 
respondents report the abilities of eating, washing or dressing by themselves. The 
descriptive part produces a five-digit number describing a health profile, and the 
descriptive system generates 243 possible different health profiles that may be indexed 
in a health preference weight, the EQ-5Dindex. There are several value sets that can be 
used to calculate an overall preference value.
181 
Because there is no Swedish value set, 
the UK EQ-5Dindex value set
182
 was used in this thesis.  
(2) The second part of the instrument is the EQ VAS, a 100-point visual analogue scale 
with two anchor points where 0 represent worst imaginable health and 100 is best 
imaginable health.  
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A study-specific questionnaire was developed by the authors to collect data on physical 
symptoms, comorbidities, perceived recovery and social aspects of HRQoL (housing 
situation, work, economy, life-style, personality and family life. The study-specific 
questionnaire was developed from a literature review, interviewing patients and 
discussions with experts in the area.  
 
5.3.2 Clinical classifications 
At hospital admission the patient‟s level of consciousness was assessed with the 
Glasgow Coma Scale, GCS.
60
 The patient‟s neurological status at admission was 
assessed with the Hunt and Hess classification (H&H) of SAH.
61
 Neurological outcome 
at hospital discharge was assessed by clinicians with the Glasgow Outcome Scale, 
GOS.
83
   
 
5.3.3 Diagnostic classifications 
The International Classification of Diseases (ICD) is an international diagnostic 
classification for epidemiological, health management and clinical use. WHO 
nomenclature regulations stipulate the use of ICD in its most current revision for 
mortality and morbidity statistics by all WHO member states.
141
 The ICD is revised 
periodically and is currently in its tenth revision, ICD-10. The previous revision, ICD-
9, was used in Sweden between 1987 and 1996. For eligibility of the samples in this 
thesis, patients diagnosed with the following ICD codes were assessed; ICD-9 code 430 
(SAH, ruptured aneurysm), and the ICD-10 codes: I60.0 –I60.9 (SAH of different 
origins). Only patients with verified ruptured aneurysms were included.  
 
5.3.4 Procedures 
Paper I: Patients were identified from the hospital‟s database of admitted patients, and 
controlled against the neurosurgical clinic‟s intensive care registry. A request of study 
participation, study information and questionnaires (STAI, HADS, EQ-5D, study-
specific) along with informed consent were sent to the patients‟ homes approximately 
six months after the hospital admission. When questionnaires and signed consent forms 
were returned, a structured telephone interview was conducted (using BI and TICS), 
and to collect any missing data. The same procedures were repeated one year and two 
years after the rupture. One reminder call was made if the questionnaires were not 
returned within a two-week time period. Demographic data and clinical variables were 
retrospectively collected from digital patients‟ records. The data collection continued 
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from April 2006 to October 2009. In this thesis, only data from the study-specific 
questionnaire is presented. 
 
Papers II-IV: Patients admitted for aneurysm rupture 1996-1999 were retrospectively 
identified through clinic patient registers based on ICD-9 and ICD-10 diagnoses. Living 
patients were identified through medical records, and they received a request of study 
participation along with informed consent, study information, and questionnaires 
(STAI, HADS, EQ-5D, study-specific) approximately ten years after aneurysm rupture. 
One reminder call was made if the questionnaire was not returned within a two-week 
time period. After signed consents and questionnaires were returned, a structured 
telephone interview was conducted for assessment of ADL and cognitive status. The 
data collection period for the data in papers III and IV continued in 2007-2008. Data on 
the diseased patients were obtained from paper and digital patient records and from the 
Swedish Cause of Death Register. The data collection in paper II was completed in 
December 2009. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
5.4 DATA ANALYSIS 
An overview of methods for analysis is presented in table 4, and analyses are described 
in detail below. Statistical significance was set at p < 0.05. Statistical analyses were 
performed by SPSS16.0 and SPSS 19.0 for Windows.  
 
Table 5. Overview of statistical methods and qualitative analysis used in papers I-IV 
Analyses Paper 
I II III IV 
Mann-Whitney U test  X X  
Kruskal-Wallis one-way analysis of variance   X  
Spearman’s rank correlation coefficient   X  
Multiple regression analysis    X 
Logistic regression analysis   X  
Cronbach’s alpha   X  
Chi-square test  X   
Fisher’s exact test  X  X 
Independent sample t-test  X  X 
Kaplan-Meier analysis  X   
Log-rank test  X   
Qualitative content analysis X    
Cochran’s Q-test X    
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Paper I: The sample size was determined though a power calculation to detect a 
difference in the mean value of 5 points on the instrument State Trait Anxiety Inventory 
(STAI), with a statistical power of 80% and an alpha value of 0.05. The power 
calculation showed that that at least 28 individuals in each group (treatment type and 
gender) were needed.  
     An exploratory mixed methods approach was used, combining quantitative and 
qualitative data
183
. The purpose of choosing this approach was to create a 
complementarity; to be able to describe a fuller picture of perceived changes in life 
after aneurysm rupture, as well as to compare and contrast variables. During the data 
collection, intramethod mixing was used with a questionnaire that included both 
quantitative and qualitative components.
184
 The quantitative and qualitative data were 
given equal priority and were analyzed parallel with statistics and qualitative content 
analysis.  
      The quantitative data were analyzed with descriptive statistics. Reported changes 
within everyday activities and within mood or personality were dichotomized into two 
categories and compared; no and small changes, versus moderate and large changes. To 
analyze differences between the three follow-up points, Cochran‟s Q-test was used. 
     The textual data were analyzed using manifest content analysis as described by 
Graneheim & Lundman.
185
 Content analysis is a systematic research method to make 
valid inferences from verbal, visual or written data, in order to describe or quantify 
specific phenomena. Content analysis can be used alone or in conjunction with other 
methods. Analysis can be quantitative and merely count frequencies, or qualitative, 
aiming to provide knowledge and understanding of the phenomena under study.
186
 
Qualitative content analysis that describes the visible and obvious content are referred 
to as manifest analysis, and  analysis of the underlying meaning is referred to as latent 
analysis.
185
  
     Before the analysis began, the material was read repeatedly to gain an overview. The 
analysis was thereafter carried out in a back-and-forth  movement between the whole 
and parts of the text in the following steps: (1) the text was sorted into content areas 
according to specific topics in the questionnaire, (2) the text was divided into meaning 
units, relating to the central meaning of the content area, (3) the meaning units were 
condensed to shorten the text while preserving the central core, (4) the condensed 
meaning units were labeled with a code to enable abstraction, (5) sub-categories were 
formed by related codes, and  (6) categories were formed by related sub-categories.  
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Paper II: In this paper epidemiological differences between men and women, and 
treatment modalities were examined. To analyze the overall gender distribution of 
aneurysm rupture, the Chi-square test was used. Fisher‟s exact test was used to analyze 
differences between patients treated with clipping and coiling, and differences between 
men and women. For normally distributed data such as age at aneurysm rupture and age 
at death, independent sample t-test was used. Mann-Whitney U test was used for 
comparing not normally distributed interval data, that is to say the differences in 
frequency of aneurysms between men and women. Ninety-five percent confidence 
intervals (CI) for proportions were calculated, estimated by normal binomial 
distribution. Kaplan-Meier analysis and log-rank test were used for testing equality of 
survival time across gender and treatment modalities. The incidence of ruptured 
aneurysms per 100 000 person-years was calculated from male, female and overall 
population data in Stockholm County per year from 1996-1999, 
142
 and were analyzed 
by calculating 95% CI according to method by Schoenberg.
187
 In this method, table 
values based on Poisson distribution are used to calculate confidence intervals in neuro-
epidemiologic studies.
187
 
 
Paper III: Comparisons between the following groups were made: men and women, 
age groups and aneurysm location. In the analysis, three age groups were formed; 24-
45, 46-65, and >65 years. Aneurysm locations were dichotomized into anterior and 
posterior circulation of the brain; aneurysms in the anterior circulation include all 
arteries forward of the posterior cerebral artery, and posterior circulation comprises the 
posterior cerebral artery and all arteries backwards. 
     Data were not normally distributed and nonparametric tests were used. For 
comparisons in three age groups, Kruskal-Wallis one-way analysis of variance was 
used. Mann-Whitney U test was used for comparisons between groups 
(anterior/posterior circulation of brain, respondents with/without untreated aneurysm or 
base remnant). Spearman‟s rank correlation coefficient was used for examining 
association between age and cognitive function on the TICS. The internal consistency 
of STAI, HADS and BI were calculated by using Cronbach‟s alpha. Logistic regression 
analysis was used to predict psychiatric disorder with HADS total as the dependent 
variable. 
 
Paper IV: In this paper, respondents treated for aneurysm rupture were compared to a 
general population sample. Subgroup analyses in the aneurysm sample were 
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performed; respondents with comorbidities were compared with respondents without 
comorbidities, stratified into three age groups: 24-45, 46-65 and 66-90 years, due to the 
fact that comorbidities are more common with increasing age. Respondents differing in 
perceived recovery were compared and perceptions of recovery were dichotomized; 
respondents not at all or partly recovered were compared to respondents fully or mostly 
recovered. Respondents differing in neurological outcome on GOS at hospital 
discharge were compared; respondents assessed as GOS 2-3 were compared to GOS 4-
5. Active aneurysm treatment modalities were compared; open surgery treated versus 
respondents treated with endovascular procedure. In this comparison one 
conservatively treated respondent was excluded. In order to investigate HRQoL in 
relation to close family support respondents differing in marital status were compared; 
those living alone were compared to those who were married and cohabitants. To 
analyze differences between groups, Fisher‟s exact test and t-test were used. Moderate 
and severe levels on EQ-5D dimensions were collapsed before analysis. Multiple 
regression analysis was used to study how the EQ-5Dindex varied with sex, age, 
comorbidity, perceived recovery, neurological outcome, aneurysm treatment and 
marital status. All explanatory variables were entered as dummy (0/1) variables. 
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6 ETHICAL CONSIDERATIONS 
 
In Sweden, research involving humans is regulated in a legal act with the purpose of 
protecting individuals and human dignity when research is conducted.
188
 The conducted 
data collections in this project followed the ethical principles of medical research 
involving humans outlined in the Helsinki Declaration.
189
 The Declaration of Helsinki 
was adopted by the World Medical Association 1964, and was last amended in 2008. 
The Declaration of Helsinki is a statement of ethical principles for medical research 
involving humans and binds the researcher to protect life, health, dignity, integrity, 
right to self-determination, privacy and confidentiality for the research subjects.
189
 
 
Before conducting the studies, an assessment of predictable risks and benefits was 
performed. Predictable risks for patients participating in this research project were 
assessed to be: possible increased anxiety due to follow-up sessions, and that some 
questions may be seen as intrusive and possibly violating their personal integrity. These 
risks were judged largely preventable through information concerning confidentiality 
and follow-up telephone calls. The predictable benefit for the respondents was that they 
may feel a sense of security when contacted and followed-up by someone familiar with 
the specific problems that may follow an intracranial aneurysm rupture. 
     Study information and consent forms were sent to the respondents along with the 
self-reported questionnaires. A signed informed consent form was obtained from each 
respondent. In the study information, voluntary participation was emphasized and 
confidentiality was guaranteed. The subjects were informed that their decision whether 
to participate or not, as well as interrupted participation, would not affect their ordinary 
or future care. All data collection was done with no possible dependent relationship 
between the researcher and the patients. To ensure confidentiality, all questionnaires 
were provided with a respondent-specific code number. The identifying code list was 
stored in a locked cabinet and kept separate from the completed questionnaires. 
 
The Stockholm regional board for ethics of research involving humans approved the 
project (registration numbers 2006/1431-31/1, 2006/283-31/3). 
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7 RESULTS 
 
The results from papers I, III and IV are presented in the form of the dimensions of 
HRQoL, formulated by de Haan et al.
10,11
 and described in the background section of 
this thesis.  
 
7.1 PHYSICAL DIMENSION OF HRQOL 
During the first two years following an intracranial aneurysm rupture, several aspects 
of physical impact are described (paper I). A variety of physical symptoms originating 
from the aneurysm rupture were described, such as different types of pain, loss of smell 
or taste ability, and a sensitivity for stimuli. This sensitivity was expressed as sensitivity 
to sounds, strong light, and being in crowds or stressful situations. In papers I and III, 
problems with disruption of night sleep, daytime sleepiness and fatigue were reported. 
Problems in all these three areas were reported by 48.9% (n = 43) at six months, 57.5% 
(n = 50) at one year, and 46.4% (n = 39) at two years (paper I). At ten years, problems 
in all three areas were reported by 42.9% (n = 93) (paper III). Table 6 shows reported 
problems with night sleep, daytime sleepiness and fatigue at different time points. 
 
Table 6. Reported sleep-wake disorders and fatigue 6 months, 1 year, 2 years (paper I) 
and 10 years (paper III) after aneurysmal SAH 
Assessment area and 
degree of rated problems 
Follow-up at  
6 months,  
n = 88 
Follow-up at  
1 year,  
n = 87 
Follow-up at  
2 years,  
n = 84 
Follow-up at  
10 years,  
n = 217 
n (%) n % n % n % 
Disruption 
of night 
sleep 
None 35 (39.8) 32 (36.8) 34 (40.5) 89 (41.0) 
Some  27 (30.7) 30 (34.5) 33 (39.3) 61 (28.1) 
Moderate  19 (21.6) 17 (19.5) 10 (11.9) 38 (17.5) 
Severe  7 (8.0) 8 (9.2) 7 (8.3) 29 (13.4) 
Daytime 
sleepiness 
None 10 (11.4) 13 (14.9) 13 (15.5) 64 (29.5) 
Some  45 (51.1) 38 (43.7) 38 (45.2) 74 (34.1) 
Moderate  21 (23.9) 28 (32.2) 23 (27.4) 60 (27.6) 
Severe  12 (13.9) 8 (9.2) 10 (11.9) 19 (8.8) 
Fatigue None 23 (26.1) 18 (20.7) 27 (32.1) 79 (36.4) 
Some  32 (36.4) 34 (39.1) 26 (31.0) 67 (30.9) 
Moderate  24 (27.3) 25 (28.7) 25 (29.8) 49 (22.6) 
Severe  9 (10.2) 10 (11.5) 6 (7.1) 22 (10.1) 
 
Post-stroke fatigue was described as chronic or extreme tiredness with an increasing 
need for rests or naps to manage the day. The post-stroke fatigue affected social life, 
working life and intimate relations (paper I). 
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7.2 FUNCTIONAL DIMENSION OF HRQOL 
Mobility and activities of daily living ten years after the onset of aneurysmal SAH were 
assessed with the instrument BI (paper III). The values ranged from 20-100 and a 
majority of respondents (84.4%, n = 184) rated the maximum value of 100. A small 
proportion rated disabilities in varying degrees; 11.1% (n = 24) had mild physical 
disabilities, 1.4% (n = 3) had moderate disability and 2.8% (n = 6) had severe 
disability. Coefficient alpha for BI was 0.91. 
     Mobility ten years after the onset was also measured and compared to a general 
population sample in the dimension „mobility‟ on the instrument EQ-5D (paper IV). 
The comparison showed significantly more problems with mobility in the aneurysm 
sample (table 7). 
     Ten years after aneurysmal SAH the aneurysm sample reported significantly more 
problems in the EQ-5D dimension self-care compared to the general population sample 
(table 7).  
 
     
 Table 7. Percentage (number) of respondents reporting no, moderate and severe problems in EQ-5D dimensions, EQ-5Dindex and  
EQ VAS values, aneurysm sample and general population sample (paper IV)  
 Total     Men     Women    
 
EQ-5D dimensions 
Aneurysm 
sample  
n = 217 
 General  
population sample  
n = 434 
 Aneurysm 
sample  
n = 63 
 General  
population sample 
 n = 126 
 Aneurysm 
Sample 
 n = 154 
 General  
population sample  
n = 308 
 % (n)  % (n) P
 a, b  % (n)  % (n) P
 a, b  % (n)  % (n) P
 a, b 
Mobility      <.001        .007         .010   
No problems 71.0 (154)  83.6 (363)   68.2 (43)  85.7 (108)   72.1 (111)  82.8 (255)  
Moderate problems 26.7 (58)  16.4 (71)   27.0 (17)  14.3 (18)   26.6 (41)  17.2 (53)  
Severe problems 2.3 (5)  0.0 (0)   4.8 (3)  0.0 (0)   1.3 (2)  0.0 (0)  
                     
Self-care      .002        .016        .026   
No problems 92.6 (201)  97.9 (425)   92.0 (58)  99.2 (125)   92.9 (143)  97.4 (300)  
Moderate problems 6.0 (13)  1.4 (6)   4.8 (3)  0.8 (1)   6.5 (10)  1.6 (5)  
Severe problems 1.4 (3)  0.7 (3)   3.2 (2)  0.0 (0)   0.6 (1)  1.0 (3)  
                     
Usual activities      <.001       <.001 
 
           .019  
No problems 74.7 (162)  87.8 (381)   69.9 (44)  92.9 (117)   76.6 (118)  85.7 (264)  
Moderate problems 20.3 (44)  11.1 (48)   22.2 (14)  7.1 (9)   19.5 (30)  12.7 (39)  
Severe problems 5.1 (11)  1.2 (5)   7.9 (5)  0.0 (0)   3.9 (6)  1.6 (5)  
                     
Pain/discomfort      .506        .760         .322  
No problems 49.8 (108)  46.8 (203)   50.8 (32)  53.2 (67)   49.4 (76)  44.1 (136)  
Moderate problems 42.4 (92)  48.8 (212)   36.5 (23)  43.6 (55)   44.8 (69)  51.0 (157)  
Severe problems 7.8 (17)  4.4 (19)   12.7 (8)  3.2 (4)   5.8 (9)  4.9 (15)  
                     
Anxiety/depression      .001        .045         .007  
No problems 56.7 (123)  70.3 (305)   58.7 (37)  73.8 (93)   55.9 (86)  68.8 (212)  
Moderate problems 37.3 (81)  27.9 (121)   38.1 (24)  23.8 (30)   37.0 (57)  29.6 (91)  
Severe problems 6.0 (13)  1.8 (8)   3.2 (2)  2.4 (3)   7.1 (11)  1.6 (5)  
                     
EQ-5Dindex mean (±SD) 0.74 (±0.31)  0.81 (±0.22) <.001  0.71 (±0.36)  0.84 (±0.21) .002  0.75 (±0.28)  0.80 (±0.22) .029 
EQ VAS mean (±SD) 70.7 (±22.1)  77.6 (±18.0) <.001  71.4 (±21.5)  78.1 (±16.9) .021  70.4 (±22.5)  77.4 (±18.4) <.001 
               
a
 Differences between aneurysm sample and general population sample  
b
 Moderate and severe levels in EQ-5D dimensions collapsed before analysis
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7.3 PSYCHOLOGICAL DIMENSION OF HRQOL 
Cognitive function 
During the first two years following aneurysmal SAH, the impact on cognition in terms 
of affected memory, executive functions and perception were described (paper I). 
Different aspects of memory problems were described, such as difficulty to remember 
names, words and places. The affected executive functions were expressed as: having 
difficulty to initiate, to concentrate, perform long-term planning and to maintain 
activities. Affected perceptions were expressed as having a slower perceptual speed, 
they felt slow in discussions, had poorer listening comprehension and had difficulty 
interpreting irony and witty humor. 
     Ten years after aneurysmal SAH, cognitive status was assessed using TICS (paper 
III). The values on TICS ranged between 13-40 points (md = 33.0, IQR = 31.0 – 36.0); 
21.7% (n = 45) scored ≤ 30 which indicates impaired cognitive function. Respondents 
aged over 65 years (n = 76) scored significantly lower on TICS compared to younger 
age groups (p < 0.001). Higher age correlated negatively with cognitive function on 
TICS (rs = -0.322, p < 0.001), indicating that higher age is related to decreased 
cognitive function.  
 
Emotional status, mood and personality 
The first two years following aneurysmal SAH, the majority of respondents rated 
changes in mood and/or personality to some extent: 73.9% (n = 65) at six months, 
75.9% (n = 66) at one year, and 72.6 (n = 61) at the two-year follow-up (paper I). These 
changes were consistently reported during the follow-up points. Mood changes were 
expressed in the different aspects of feeling blue, being less happy and being depressed. 
An increased level of anxiety was also expressed; anxiety for a new SAH from the 
previously ruptured aneurysm or another aneurysm, concerns for their own abilities, 
and a general feeling of anxiety. The mood stability was also affected, with respondents 
reporting that they could not control their emotions, expressed as having mood swings, 
they were easily irritated and impatient, they were quick to anger, and that their anger 
was likely to „explode‟. Emotional lability was also expressed and was described as 
being more sensitive or sad, to cry for no reason and to cry easily. 
     The perceived changes in personality included altered behavior, new perspectives on 
life and new feelings. The altered behavior experiences could be placed on a continuum 
between two extremes; some respondents described their personality as more introvert, 
that they were calmer, more thoughtful, less spontaneous and more serious than before 
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the onset. Others described an opposite change to a more extrovert personality, to be 
more straightforward, more social, and more assertive after the onset. The new 
perspectives on life were expressed as: that they valued new or other things than before, 
that they were grateful to be alive, and that they prioritized differently after the onset. 
The respondents expressed that they felt more vulnerable after the onset; they felt 
insecure and had poorer self-esteem. 
 
Ten years after aneurysmal SAH, symptoms of anxiety and depression were measured 
with STAI and HADS (paper III), and also with the dimension of anxiety/depression on 
the EQ-5D self-classifier (paper IV). The majority of respondents (52.5%, n = 114) 
scored higher than the Swedish population norm mean value of 33.2 on total STAI. 
Significantly more symptoms of anxiety and depression were found in respondents with 
ruptured aneurysms in the posterior circulation of brain. Table 8 shows the median and 
inter quartile range (IQR) on STAI and HADS for the total sample and 
anterior/posterior circulation, and values from two reference populations. 
 
Table 8. Psychological function for total sample and by aneurysms in the anterior and 
posterior circulation, and reference groups (paper III) 
Instrument Aneurysm sample  
md (IQR) 
 
 
Reference groups 
(Central tendency and dispersion) 
Total 
sample 
n = 217 
Anterior 
circulation 
n = 199 
Posterior 
Circulation  
n = 18 
p 
STAI 
1)
 
 
 
34.0 
(28.0-47.0) 
34.0  
(27.0-46.0) 
46.0 
(39.0-56.5) 
0.002 median 32 
m (SD) = 33.2  
(± 9.6) 
Randomized 
Swedish sample,  
n = 180,   
26-65 years
190
 
HADS-A 
2)
 
 
5.0 
(1.0-9.0) 
4.0  
(1.0-8.0) 
9.0  
(4.8-12.5) 
0.001 Median 4.0 
IQR = 2.0-7.0 
Randomized 
Swedish sample,  
n = 624,  
30-59 years
191
  
HADS-D 
2)
 
 
4.0 
(1.0-7.0) 
3.0  
(1.0-7.0) 
6.5  
(2.8-10.0) 
0.036 
 
Median 3.0 
IQR = 1.0-6.0 
 
HADS total 
3)
 
 
8.0 
(4.0-15.5) 
8.0  
(3.0-15.0) 
15.0  
(10.8-21.2) 
0.001 
 
Median 7.0  
IQR = 4.0-12.0 
 
1)
 Higher scores STAI total indicate higher levels of anxiety 
2)
 Higher scores on HADS subscales indicate more anxiety or depression 
3)
 Higher scores on HADS total scale indicate psychiatric disorder 
 
On the HADS anxiety subscale (HADS-A) 33.6% (n = 73) scored anxiety symptoms; 
16.1% (n = 35) were identified as mild cases, 12.0% (n = 26) were moderate cases and 
5.5% (n = 12) were severe cases. On the HADS depression subscale (HADS-D) 23.5% 
(n = 51) scored for depressive symptoms; 15.7% (n = 34) mild cases, 6.0% (n = 13) 
moderate cases and 1.8% (n = 4) severe cases. Respondents older than 65 years had 
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significantly lower scores on HADS-A compared to younger age-groups (p = 0.004). 
On HADS total scale 41.9% (n = 91) scored ≥ 11 points, indicating a psychiatric 
disorder. A logistic regression analysis showed that the primary predictor for a 
psychiatric disorder was aneurysm location. Aneurysm rupture in the posterior 
circulation of the brain increased the odds ratio for a psychiatric disorder (5.5, 95% CI 
= 2-17, p = 0.04), R
2
 = 9% (χ2 = 14.9, df = 4, p = 0.005). 
     Cronbach‟s alpha for STAI was 0.95. Alpha coefficient for total HADS was 0.91, 
and for HADS anxiety and depression subscales coefficients were 0.91 and 0.82, 
respectively. 
     On the EQ-5D self-classifier, the aneurysm sample reported significantly more 
problems (p < 0.001) in the dimension anxiety/depression compared to the general 
population sample (paper IV). 
 
Overall perception of health 
Overall perception of health was measured ten years after aneurysmal SAH with EQ-
5Dindex and EQ VAS (paper IV). EQ-5Dindex ranged from -0.484 to 1.0; 78 respondents 
(35.9%) reported full health (1.0), and 6 respondents had index values below zero. In 
the EQ VAS, where overall health was reported, values ranged from 0-100, and full 
health (EQ VAS = 100) was rated by 5.1% (n = 11). When the aneurysm sample was 
compared to a matched general population sample (table 7), the aneurysm sample had 
significantly lower EQ-5Dindex and EQ VAS values. Subgroup analyses were performed 
in the aneurysm sample and the results showed that those with low perceived recovery 
had significantly lower EQ-5Dindex (m = 0.45 versus m = 0.85, p < 0.001) and EQ VAS 
values (m = 50.5 versus m = 78.6, p < 0.001). When respondents differing in 
neurological outcome were compared (GOS 2-3 versus GOS 4-5), those with worse 
neurological outcome had significantly lower EQ-5Dindex (m = 0.52 versus m =0.79, p < 
0.001) and EQ VAS values (m = 50.5 versus m = 72.9, p = 0.002). Subgroup analyses 
were also performed between those with comorbidities (n = 99), and without 
comorbidities (n = 118), and the results showed significantly lower EQ-5Dindex (m = 
0.81 versus 0.65, p < 0.001) and lower EQ VAS values (m = 76.0 versus 64.3, p < 
0.001) for respondents with comorbidities. When controlling for age and sex in 
regression analyses it was shown that those with worse neurological outcome, with 
comorbidities and with low perceived recovery had significantly lower EQ-5Dindex. 
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7.4 SOCIAL DIMENSION OF HRQOL 
Several social consequences were revealed during the first two years following 
aneurysm rupture, with changes in social contacts and interactions (paper I). Most 
changes in family life were reported at 6 months. The most frequent type of change at 
all three follow-up points were changed social roles (n = 18), followed by separation or 
divorce (n = 8). Other described changes were to be unable take care of children  
(n = 2), and positive changes; that they had married or moved in together with a partner 
(n = 3). The respondents described that they were involved in fewer social activities, 
were less involved in the lives of others, that they had lost friends and had difficulties in 
interacting with others – leading to isolation. Some expressed that they chose to be 
lonely, while others described that loneliness was a consequence of people behaving 
differently towards them. The SAH had impacted on the close relationships with family 
and friends, described as changed social roles, separations and divorces, and altered 
friendship relations, but also that some relationships were valued more after the illness. 
The time to return to work ranged between 2.5 to 24.0 months (md = 5.0, IQR = 4.0-
12.0) and the proportion that were working part- or full-time were 30.7% (n = 27) at six 
months, 36.8% (n = 32) at one year, and 51.2% (n = 43) two years after the onset. 
Those who had returned to work expressed difficulties in the working situation; they 
found it hard to manage the previous workload due to concentration difficulties and 
tiredness, and described different strategies to manage work, such as memorizing tasks 
beforehand, and adjustments that their employer had done to make it possible to 
manage workload. Examples given for adjustments were; holding a new position with 
less responsibility, other or easier tasks, shorter working hours, and help and support 
from colleagues.  
 
At ten years post-aneurysm rupture, the social domain of HRQoL was assessed with the 
dimension „usual activities‟ in the EQ-5D descriptive system (paper IV). The results 
showed a significantly higher proportion of aneurysm respondents scoring for problems 
compared to the general population sample (table 7).  
 
7.5 EPIDEMIOLOGICAL OUTCOMES 
Epidemiology was analyzed in relation to gender differences and treatment modalities 
(paper II). The female incidence was higher than that of men in all four followed year 
groups; table 9 shows the incidence per 100 000 person years in Stockholm 1996-1999. 
 
   41 
 
Table 9. Incidence of aneurysmal SAH/100 000 person years in  
Stockholm County Council, 1996-1999 (paper II) 
Year All Men Women 
1996 7.2 (6.0-8.6) 4.0 (2.8-5.6) 9.1 (7.3-11.2) 
1997 7.1 (5.9-8.5) 4.5 (3.2-6.2) 9.5 (7.6-11.8) 
1998 5.9 (4.9-7.2) 4.4 (3.1-6.0) 7.4 (5.8-9.5) 
1999 5.7 (4.6-6.9) 2.7 (1.7-4.0) 8.5 (6.7-10.6) 
95% CI is shown in parentheses 
 
The women were older at the onset of aneurysm rupture (mean age 55.7 versus 52.8 
years, p = 0.027) and they were diagnosed with significantly more aneurysms 
compared to the men; 88 of the women (26.7%, 95% CI: 22.0 – 31.5) and 23 of the 
men (16.5%, 95% CI: 10.4 – 22.7) were diagnosed with multiple aneurysms.  
 
The majority of the ruptured aneurysms (n = 419, 89.5%) were located in the anterior 
circulation of the circle of Willis, and most common locations for both men and women 
were ACoA (n = 168, 35.9%) followed by MCA (n = 129, 27.6%). Significant gender 
differences (p < 0.001) in proportions were found when comparing aneurysm locations; 
aneurysms in the ICA area were more common in women (25.8%, n = 85) compared to 
the men (8.6%, n = 12). Aneurysms in the ACA area were more common in men 
(53.8%, n = 81) compared to the women (34.0%, n = 112). 
 
Ten years after aneurysm rupture, 63.9% (n = 296) of patients were still alive. There 
were no significant differences in mean survival time between men and women; for 
men 6.8 years (95% CI: 6.1 – 7.5) versus 7.2 years (95% CI: 6.8 – 7.7) for women.     
     Comparison of mean survival time between treatment modalities showed 
significantly lower survival  (p < 0.001) for conservatively treated patients (0.8 years, 
95% CI: 0.3 – 1.4) compared to patients treated with clipping (8.4 years, 95% CI: 8.1 – 
8.8) and endovascularly treated patients (8.2 years, 95% CI: 7.4 – 9.1). 
     The mortality was highest in the first month after the rupture, due to the initial 
hemorrhage. Deaths after the first year were not related to the ruptured aneurysm, but to 
cardiovascular diseases and malignancies. 
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8 DISCUSSION 
8.1 GENERAL DISCUSSION 
Impact on life 
Aneurysmal SAH impacts upon life and health in several ways on a long-term basis 
after the onset. During the first two years, transitions are ongoing with changes in 
personality, social roles, abilities and behavior. Transitions and change are not 
synonymous; change is to substitute one thing for another and is an external process, 
while transition is an internal process that incorporates changes in identity, roles, 
relationships, abilities and behavior.
192
 Transition requires that new knowledge is 
incorporated and that behaviors are altered and therefore requires people to change the 
definition of self in a social context.
138
 Emotional distress in terms of anxiety, 
depression, insecurity and frustration are common during the transition process.
136
 
When successful transition has occurred, the distress gives way to well-being.
136
 The 
results reveal transition in more than one area, or multiple transitions; 
139
 health /illness 
transition caused by the differences in health status after the aneurysm rupture with 
physical and psychological consequences, and also situational transition, caused by a 
changed family situation and changes in professional role. Some of the transitions seem 
to be sequential and overlap, while others seem to appear to be simultaneous.  
 
The respondents in paper I expressed an increased level of anxiety and a more 
depressed mood than before the aneurysm rupture. This finding could be interpreted as 
process indicators, a response to changes in self-concept, self-esteem and social 
roles.
135
 However, the high levels of anxiety and symptoms of depression seem to be 
continuous; when comparing reported problems on the dimension anxiety/depression 
the EQ-5D self-classifier (paper IV), the aneurysm respondents report significantly 
more problems than the general population sample, ten years after the onset. 
     Symptoms of depression were further assessed ten years after the aneurysm rupture 
(paper III), and the results showed that about a quarter of respondents scored for 
depressive symptoms. This proportion corresponds to results from previous studies 21-
36 months after aneurysm rupture, 
95,113,114
 and 7-9 years after the onset.
107,115
 When 
anxiety was assessed ten years after the onset (paper III), the median values were 
greater for the aneurysm respondents, when compared to Swedish norm 
populations.
190,191
 Our results show that ten years after the onset, about one-third of 
respondents scored anxiety symptoms, which corroborates with the results by Visser-
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Meily et al.
114
 36 months after aneurysmal SAH. The similarity in results between 
previous studies and our results on the proportion of respondents with symptoms of 
depression and anxiety indicates that the levels of anxiety and symptoms of depression 
may be unchanged many years after the onset. The highest levels of anxiety and the 
most symptoms of depression ten years after the onset were found in patients with 
ruptured aneurysms in the posterior circulation of the brain, which predominantly were 
treated endovacularly (paper III). Endovascular treatment, in the literature, is associated 
with more frequent radiological follow-up,
193
 and it could then be suggested that 
recurrent follow-up sessions may serve as reminders of the previous aneurysm rupture 
and produce more anxiety and depression. However, the radiological follow-up at the 
clinic is similar between surgically- and endovacularly-treated patients and does not 
provide any explanation for this theory. One previous study has examined symptoms of 
anxiety and depression in relation to aneurysm location, but reported no significant 
differences.
107
 
 
Decreased cognitive functions were described the first two years following aneurysm 
rupture, in terms of memory problems, lowered executive functions and a slower 
perceptual speed. When cognitive status was assessed ten years after the onset, 21.7% 
scored with cognitive impairments and had, on a group level, a lower cognitive 
function when compared to published norm data on healthy controls.
169
 Our percentage 
of cognitively impaired differs largely to previous studies where the majority of 
patients were cognitively impaired up to five years after the onset.
121,122
 It has to be 
considered that the TICS instrument does not provide a complete array of information 
on cognition; some of the respondents may suffer from clinically significant 
impairments that are not covered by the instrument. 
 
Approximately one-third of respondents in papers I and III report moderate and severe 
problems with disruption of night sleep and daytime sleepiness. This proportion is 
similar to results from previous studies 1-7 years after aneurysmal SAH.
104-106
 Sleep-
wake disorders may play a role in fatigue,
103
 about one-third of respondents also 
reported moderate and severe problems with fatigue. This is a higher percentage of 
respondents affected by fatigue than previously reported results by Wermer et al., 
107
 
where 17% reported subjective fatigue nearly nine years after the onset. Post-stroke 
fatigue is a complex problem to study because of the diversity of its manifestations, 
there is a lack of objective instruments to measure it, and the underlying 
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neurobiological mechanisms are unknown.
103
 The diversity of manifestations and lack 
of objective instruments to measure post-stroke fatigue may explain differences in 
proportions of affected patients between studies. Fatigue may have a major impact on 
quality of life after stroke, despite the fact that neurological or cognitive sequel cannot 
be found, and may prevent patients to resume social and professional activities.
103
 This 
can be illustrated by the results in paper I, where fatigue is described to affect social 
life, working life and also intimate relations. Although fatigue is a well-known health 
problem after stroke, there is still insufficient evidence to guide the management of 
post-stroke fatigue.
194
 Stone
195
 describes cognitive difficulties and fatigue after 
hemorrhagic strokes as „invisible‟ disabilities; when disabilities are not obvious, stroke 
patients may nevertheless live with impairments that limit their ability to fully meet 
social expectations.  
 
Ten years after aneurysm rupture the majority of respondents scored the maximum 
value on BI, indicating they were managing activities of daily living independently, 
while a small proportion, 2.8%, scored severe physical disability (paper III). These 
results are similar to the results in paper IV, where 2.3% reported severe problems with 
mobility and 1.4% reported severe problems with self-care on the EQ-5D self-
classifier. The meta-analyses by Nieuwkamp et al.
94
 and Hop et al.
93
 showed that 10-
20% of respondents were dependent on help for activities on daily living after the 
onset. This discrepancy with the results in this thesis may be explained by the time of 
follow-up; the majority of participants in the aforementioned studies were followed-up 
during the first 12 months after the onset, and the physical ability is expected to 
improve to some degree after the first year. Although a small proportion of respondents 
were severely disabled, the results in paper IV show significantly more problems with 
mobility and self-care are present, when compared to the general population. 
 
Social life is also affected in several ways after aneurysmal SAH; isolation from 
previous social life, changes in family life and in working life (paper I). Ten years after 
aneurysm rupture, respondents report significantly more problems with usual activities 
when compared to the general population (paper IV). Negative social consequences 
after stroke have been addressed in a systematic review reporting deterioration of 
leisure activities in 15-79% of cases, negative impact on family relationships 5-54%, 
and inability to return to work 0-100%.
130
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     During the first two years after onset, social relationships were impacted with 
changed social roles in the family, separations and divorces and altered friendship 
relations. The literature describes that the family‟s ability to provide ongoing support is 
an important factor that may facilitate or inhibit the transition process.
196
  Family 
disruption and disagreements may occur during transition, but as the transition process 
moves on, relationships may be restored with enhanced appreciation and closeness, 
which can be described in terms of family adaption.
136
 However, when the partner or 
spouse fails to adapt to the new situation, the transition is then not only inhibited, but 
also, a separation or a divorce may further lead to a new transition. 
 
Epidemiological outcomes 
The incidence declined over time (paper II), which is similar to findings in previous 
studies.
23,37,197,198
 A possible explanation for the declined incidence is a change in risk 
factors: the smoking prevalence decreased in Sweden from 1980 to 1999, in both men 
and women.
199
 Alternatively, other risk factors increased during this period: the alcohol 
consumption increased significantly in both men and women,
200
 and the proportion of 
overweight people increased, which might lead to an increased proportion of people 
suffering from hypertension. The hypertensive medical treatments increased from 1985 
to 2002.
200
 Another possible explanation is the increase of inhabitants in the Stockholm 
uptake area during 1996-1999; the population increased by 59 000 people,
142
 and the 
increase was largest in the ages below 45 years. One might suggest that people in this 
age group have lower risk of aneurysmal SAH, as the average rupture age is about 49 
years. 
24
 
 
The results in paper II show gender differences at the onset of SAH, but not in outcome 
at hospital discharge, mortality rates or survival times. The incidence was significantly 
higher in women and they were diagnosed with significantly more aneurysms; they 
were also significantly older at the onset. It has been suggested in the literature that the 
female sex hormones play an important role in the etiology, formation and growth of 
intracranial aneurysms, because the female predominance of aneurysmal SAH starts 
after menopause.
50,201
 However, these results are somewhat inconsistent; estrogen is 
presumed to have an inhibitory effect on aneurysm formation, 
201
 while high-estrogen 
oral contraceptives have been reported to increase the risk of SAH.
45
 The reasons for 
overall higher incidence in women are still unclear.
23
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     In paper II survival times were also compared between treatment modalities. 
Conservatively treated patients had significantly lower survival than patients treated 
with clipping or endovascular procedures. This result is not surprising; conservative 
treatment (i.e. no aneurysm securement) remains the only alternative for patients with 
untreatable aneurysms and patients in poor clinical grade at hospital admission. The 
risk of a fatal re-bleeding is highest the first weeks after the rupture.
63
 Survival times 
were equal between active treatment modalities (clipping versus coiling), which is 
contrary to the results of ISAT; one and five years after aneurysmal SAH significantly 
more deaths occurred among patients treated with clipping in ISAT.
88,202
 The 
differences between our results and ISAT may be explained by differences in study 
design and sampling; in ISAT aneurysms should be suitable for both clipping and 
coiling, and patients were randomized. Since a large proportion of aneurysms are not 
suitable to both treatment modalities, aneurysms in the in the posterior circulation, 
MCA aneurysms and patients in poor clinical grade are under-represented in ISAT.
203
 
In paper II, a consecutive sample of all patients were chosen and aneurysm obliteration 
method was chosen from the best evident methods, depending on aneurysm location, 
aneurysm morphology and the patient‟s clinical condition. 
 
How should follow-up be organized for aneurysmal SAH patients? 
Follow-up care after ischemic stroke varies widely, 
85
 and because aneurysmal SAH 
patients are not included in the Riks-Stroke
32
 register, important information is lacking 
for this patient group. 
     There are several reasons why aneurysmal SAH patients should be followed-up; 
firstly, in the absence of a national SAH register, the existing Swedish epidemiological 
data are insufficient. Previous studies either cover only parts of Sweden, or are based 
on retrospective data collection from the Swedish Discharge Register and the Swedish 
Cause of Death Register, including SAH of all origins. The differences between regions 
and time trends in incidence and mortality cannot be followed. 
     Secondly, for ischemic stroke patients, the Riks-Stroke register evaluates the 
perceived quality of care and community support, thus, for aneurysmal SAH patients 
these data are lacking. 
     Thirdly, ongoing transitions during the first two years indicate a need for support 
through the transitional processes. People in transition are vulnerable and may benefit 
from interventions to support them, providing knowledge of what to expect, support in 
the planning and preparation for different phases of the transition, and to find strategies 
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to manage the process effectively. Moreover, most of the adjustment to change occurs 
after being discharged from the stroke rehabilitation unit.  
     Liaison facilities, to assist the patient‟s transition from hospital to home, is a 
commonly expressed wish and need formulated by ischemic stroke patients.
204
 The 
efficacy of stroke liaison interventions has recently been explored in a meta-analysis. 
The results showed that younger patients appeared to benefit in ADL score by the 
intervention. There also appeared to be significant benefits from liaison services‟ input 
to patients with mild to moderate disability.
205
 However, in studies on stroke liaison 
facilities, the term „liaison worker‟ spans different professions including nurses, 
psychologists, social workers and also persons from the voluntary sector. The liaison 
worker‟s knowledge and skills may influence the information provision and 
counseling.
205
 Liaison services after aneurysmal SAH in terms of a neurovascular 
specialist nurse have previously been tested in an intervention study in the UK. The 
intervention group felt less anxious, and had better family relationships compared to the 
comparison group.
206
 The intervention was also cost-saving due to earlier return to 
work for the intervention group.
207
  
     Fourth, the high levels of anxiety and symptoms of depression ten years after the 
onset indicate a need for support and/or counseling long after hospital discharge. 
Survivorship care plans (SCP) may be an applicable way to support these patients. 
SCPs are used in cancer care after completion of the primary treatment and each is a 
summary of treatments and a comprehensive plan for follow-up, aiming to inform the 
patient and the patient‟s primary care provider of any long-term effects, the timing and 
content of follow-up, recommendations regarding how to maintain health and well-
being, and to identify psychosocial resources in their community.
208,209
 SCPs help 
patients and care providers to know what needs to be done, and who is responsible for 
various aspects of a person‟s care.208 In cancer care different models for delivering 
survivorship care are emerging: a shared-care model where specialists collaborate with 
primary health care providers, specialized survivorship clinics where multidisciplinary 
care is offered at one site, and nurse-led models in which nurses are responsible for 
follow-up care with oversight from physicians.
209
  
     Kirkevold
85
 emphasizes that nurses are in a unique position to provide support to 
stroke survivors because of their prominent position in hospital and primary health care 
settings. Nurse-led follow-up interventions have previously been studied in other 
patient groups, at hospital clinics, 
210
 at outpatient clinics in primary health care,
211,212
 
or by telephone.
213-215
 The results in this thesis show affected HRQoL, anxiety and 
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depression up to ten years after aneurysmal SAH; in the literature on nurse-led follow-
up, interventions do not cover such a long time span. The length of follow-up varies 
considerably between studies; from 12 months to 5 years, 
210,212,216
 and results also vary 
considerably between studies; from improved survival and self-care behavior
210
 to no 
significant differences in survival, psychological morbidity or HRQoL.
216
  
Further research is needed to find an appropriate way to follow-up and support 
aneurysmal SAH patients.  
 
 
8.2 METHODOLOGICAL CONSIDERATIONS 
This thesis includes observational studies with different designs, whereof one study 
applied a mixed methods approach. The methodological strengths in this thesis are the 
long follow-up period, the homogenous samples of aneurysmal SAH patients and the 
response rates (84.6% in paper I, respectively 79.5% in papers III and IV). Another 
strength is the completeness of data, due to the strategy that telephone interviews were 
conducted after the return of questionnaires, which enabled collection of data missing 
from the questionnaires. Methodological considerations were made concerning internal, 
external and conclusion validity of quantitative findings, trustworthiness of qualitative 
findings as well as instrument validity and reliability. 
 
Internal validity 
Internal validity in this thesis was assessed in terms of the strength of the inferences in 
the results, and whether there were other possible explanations for the obtained 
results.
217
 The risk of bias was assessed in the forms of selection of subjects, the way 
variables were measured, and if some not fully controlled confounding factors 
occurred.
218
 Selection bias was limited by using consecutive samples and including all 
eligible patients admitted for intracranial aneurysm rupture (papers I-IV).  
     In paper II, the vast majority of the included patients came from the Stockholm 
County referral area; eleven patients came from other neurosurgical clinics due to 
temporal treatment inabilities or shortage of intensive care beds. Likewise, a small 
number of patients from the Stockholm referral area were initially treated at another 
neurosurgical clinic. To avoid overestimation in the incidence calculation, the eleven 
patients from other referral areas were excluded from the incidence analysis. 
     A potential selection bias is the exclusion criteria in studies III-IV (poor health 
condition precluding participation), leading to the possibility that patients worse off 
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after the aneurysmal SAH not were included. However, the excluded patients were not 
only those that recovered least well from aneurysmal SAH, they were excluded for 
other reasons, such as severe dementia, progressive cancer disease, psychiatric disease, 
or weakness attributed to older age. In study I, the exclusion criteria included a GOS 
score lower than 3, and the excluded patients (n = 12) were those worse off after 
aneurysmal SAH. Response rate and losses to follow-up are also connected with 
selection bias.
219
 Paper I had a prospective longitudinal design, and one problem with 
this design may be the loss of some subjects between follow-up points.
219,220
 In paper I, 
a total of 4 respondents were lost from first to last follow-up point, which was not 
considered to affect the results. The response rates were considered sufficient
221
 in 
paper I (84.6% of eligible), and papers III-IV (79.5% of eligible). 
 
Retrospective data were used to collect data on medical history from patient records in 
paper II. A major disadvantage when using retrospectively collected data is that the 
data were not originally collected for the purpose of the study.
220
 If a prospective design 
would have been used in paper II, we would have been able to collect data on risk 
factors and more detailed data on medical history, but the data collection would have to 
proceed for 14 years to collect approximately the same data.  
     The term „confounding‟ could be described as a confusion or mixing of effects; the 
effect of a variable is mixed with the effect of another variable, leading to bias.
218
 
HRQoL fluctuates and is variable over time.
8
 When aspects of HRQoL are measured 
once, as in papers III and IV, numerous factors besides the aneurysm rupture may have 
affected the outcome at the time of the follow-up. Another possible confounder in paper 
III is that any previous history of depression and anxiety disorders before aneurysm 
rupture was not addressed. A limitation when using cross-sectional design is that 
measurements are conducted once, thus the independent variable of interest and the 
outcome are measured simultaneously and temporal associations cannot be 
established.
217,222,223
   
 
External validity 
External validity, the ability to generalize the study results to other populations outside 
the study setting and at other times,
217
 was also assessed, and the results were 
considered to be representative of aneurysmal SAH patients in Sweden. The 
respondents in paper II were treated during 1996-1999, and the majority were treated 
with open surgery. Rapid development in endovascular techniques, and new research 
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findings from the ISAT study have led to larger proportions of patients in many 
countries now being treated endovascularly.
72,224
 The rapid advances in both open 
surgery techniques and endovascular methodology have also decreased the proportion 
of earlier untreatable aneurysms.
73,74
 The findings concerning HRQoL and aneurysm 
treatment in paper IV and survival times in relation to treatment modalities in paper II 
may therefore not be applicable to present conditions. 
 
Conclusion validity 
Since sampling fluctuations may result in a Type I or a Type II error, 
225
 the sampling 
was also assessed. The risk of conducting a Type I error (i.e. to reject the null 
hypothesis when it is true) was controlled by using a statistical significant level of at 
least 5% throughout all analyses. The risk of a Type II error, to accept the null 
hypothesis when it is false, increases when the sample size is small.
226
 The samples in 
papers II-IV were consecutive and sample sizes were not based on sample size 
calculations. In paper II, the number of endovascularly treated patients was rather 
small, which may have ruled out a real difference (Type II error) when comparing 
survival times between active treatments. There is also a risk of Type II error in paper 
IV, as the number of respondents was small in some of the subgroup comparisons. 
     In paper I the sample was also consecutive and sample size was determined by a 
power calculation with 80% power and a significance level of 5% to detect a difference 
in the mean value of 5 points on the instrument STAI between groups (gender and 
aneurysm treatment). The power calculation showed that at least 28 individuals in each 
group were needed, which was taken into account during sampling; 30 men and 58 
women were included, respectively 34 treated with open surgery and 54 endovascularly 
treated.  
 
Trustworthiness 
One strength in using a mixed methods approach and mixing qualitative and 
quantitative data is the opportunity to get a more complete picture of a phenomenon.
227
 
Criteria to evaluate quality in mixed methods research can be gathered from both 
quantitative and qualitative orientations.
228
 In qualitative research validity, reliability 
and generalizability are assessed in terms of different aspects of trustworthiness,
185
 such 
as transferability, dependability and confirmability.
185,229
  
     Credibility/believability is the goal to demonstrate that the study was conducted in a 
way to ensure that the subjects were appropriately identified and described,
229
 and 
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refers to the focus of the study, the selection of context, study respondents and 
approach to data collection.
185
 To establish credibility it is important to choose 
respondents with various experiences to get various answers to the research question, to 
collect a sufficient amount of data, and to select the most appropriate data collection 
method.
185
 In the analysis phase, credibility deals with selecting suitable meaning units, 
and how well categories or themes cover the data. Credibility could be demonstrated by 
representative quotations from the transcribed text for the categories.
185
 In paper I, a 
relatively large consecutive sample was used, with respondents differing in ages, sex, 
aneurysm treatment and background. The sub-categories were presented with 
representative quotations to enable readers to judge the appropriateness of the 
categorization. Examples of meaning units, condensation, codes and categorization 
from the analysis were provided. 
     Transferability could be explained as how well the analyst can argue the findings of 
the study to be useful to other in similar situations, with similar questions – how well 
findings can be transferred to other groups.
185,229
 To enhance transferability, a careful 
description of context, selection of respondents, data collection and process of analysis 
is needed.
185
 In order to enhance transferability in paper I, the context and 
characteristics of the respondents have been described, as well as the data collection 
methods and a thorough description of the analysis process. Considering the relatively 
large consecutive sample (n = 88) with respondents with varying background and 
experiences, and the similar care at neurosurgical departments and rehabilitation 
nationwide, the results are transferrable to other aneurysmal SAH patients in Sweden.  
     Dependability is the degree to which data changes over time and differences in the 
analyst‟s decisions during the analysis process. If the data is collected over a long time, 
there could be a risk of inconsistency in the data collection.
185
 The data collection was 
longitudinal and continued over a long time (43 months), but was consistent with the 
same questionnaire during each follow-up, and the data analysis began when all data 
were collected. 
     Texts have no „objective truth‟, meanings are always brought to it by the reader.230 
Although manifest content analysis describes the visible and obvious content and has 
less depth and abstraction than a latent analysis, some degree of interpretation always 
occurs,
185
 and it is important to confirm and acknowledge whether another researcher 
could confirm the findings of the study, and if interpretations and logical inferences 
make sense to someone else.
229
 The first author (AvV) has extensive clinical experience 
of patients treated for intracranial aneurysm rupture, and conducted the early stage 
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analysis of the data. Henceforth, during the following analysis process, discussions 
were made with the co-authors until agreement on how the data was coded and 
categorized, and on how well categories and sub-categories covered the data.  
 
Instrument validity and reliability 
Validity refers to what extent an instrument measures what it is supposed to measure, 
and validity has different aspects.
231
 The instruments applied in this thesis have 
previously been shown to be valid and reliable instruments to use in stroke populations. 
In paper I, a study-specific questionnaire was used, developed from the literature 
review, interviewing patients and conducting discussions with experts in the field. The 
study-specific questionnaire was assessed to be face valid but further validity testing 
was not performed, which is a limitation in paper I. However, the respondents‟ answers 
adequately described the domain of interest of this study:  changes and transitions. The 
questionnaire seemed easy and clear as none of the items had high rates of non-
response. 
     Reliability refers to whether an instrument measures a target attribute consistently 
and to what extent that it measures true scores.
231
 Reliability has different aspects; one 
aspect frequently evaluated in instruments with summing items is internal consistency, 
testing that the instrument items measure the intended attributes and nothing else.
231
 
Internal consistency is a property of the scores on an instrument for a particular 
population, not of the instrument itself.
232
 In this thesis, internal consistency was tested 
for STAI, HADS (total and subscales) and BI using Cronbach‟s alpha. Cronbach‟s 
alpha should only be used in unidimensional instruments. For overall measures, where 
there are no assumptions that the individual items need to be correlated with each other, 
alpha coefficient is not useful.
233
 In research, an alpha value of 0.7 to 0.8 is regarded as 
satisfactory for comparing groups.
234
 The alpha coefficient for STAI, HADS and BI in 
paper III ranged from 0.82 to 0.91. 
 
8.3 CLINICAL IMPLICATIONS 
The results in these studies indicate a need for follow-up to enable support through the 
transitional process during the first two years, and for long-term support and/or 
counseling after aneurysmal SAH. This support should preferably be provided by 
nurses with extensive knowledge on the specific problems that could arise after 
aneurysmal SAH, irrespective if it is provided from the neurosurgery clinic or in 
primary health care.  
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To enable identification of patients needing support, some sort of screening for 
psychological distress and perceptions of health is needed. Screening could be 
performed with structured standardized instruments. If this screening is performed from 
the neurosurgical clinic, screening could be done in connection with scheduled 
radiological follow-up and could be a part of a survivorship care plan.  
 
Follow-up of this patient group is also needed for reasons other than for long-term 
support: for assessment of quality of care, and to enable the monitoring of 
epidemiological parameters, such as incidence and mortality. Since SAH patients are 
not included in the Riks-Stroke register, a national SAH register is mandated. 
 
8.4 FUTURE RESEARCH 
This thesis contributes to the knowledge about the long-term consequences of life for 
patients who suffer from intracranial aneurysm rupture. Future research could build on 
this work by conducting longitudinal follow-up studies of HRQoL and the impact on 
everyday life beyond the first two years after aneurysmal SAH. For this purpose, both 
quantitative and in-depth qualitative interview studies are needed.  
 
Future research to evaluate quality of care is recommended as these data are lacking for 
this patient group because they are not included in the Riks-Stroke register.   
 
The results indicate a need for follow-up of aneurysmal SAH patients, and a need for 
support among certain subgroups of patients. The frequency and timing of follow-up 
needs to be investigated and identification of the support needs highlights the call for 
research focusing on nursing interventions to address these needs. Moreover, 
aneurysmal SAH strikes people at a younger age than other stroke types, therefore the 
patients are more likely to be responsible for young family members and the 
consequences of the aneurysm rupture may have a much wider impact on family 
relationships. It would therefore be valuable to explore the experiences and support 
needs of the significant others. 
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9 SUMMARY AND CONCLUSIONS 
 
Ten years after aneurysmal SAH, the majority of patients were still alive. Differences 
between men and women were apparent in incidence and clinical presentation at the 
onset SAH, not in outcome at hospital discharge, mortality, or survival times. Survival 
time was equal between patients treated with clipping and endovascular procedures. 
 
The findings show that aneurysmal SAH impacts upon life and health in several ways; 
the first two years is a vulnerable period when changes and transition are common. 
Most of the process to adjust to a changed reality occurs after an eventual rehabilitation, 
but it then follows that further support from health care may be insufficient. Ten years 
after aneurysmal SAH, overall HRQoL is lower than in the general population. Levels 
of anxiety and symptoms of depression are worse than in reference populations.  
 
The results identify subgroups of aneurysmal SAH patients who might benefit from 
support: those with ruptured aneurysms in the posterior circulation of brain suffering 
from more symptoms of anxiety and depression, and the subgroups with significantly 
lower HRQoL; those with low neurological outcome at hospital discharge; those with 
comorbidities; and those with low perceived recovery. 
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10 SAMMANFATTNING (SUMMARY IN SWEDISH) 
 
Bakgrund 
Brustet pulsåderbråck i hjärnan är en livshotande sjukdom. Jämfört med andra typer av 
stroke drabbar denna typ av stroke i yngre åldrar och är vanligare hos kvinnor. 
Internationella studier har visat att andelen drabbade varierar mellan olika länder, 
befolkningsgrupper och regioner. Drabbade patienter behandlas på 
intensivvårdsavdelning och därefter på neurokirurgiska kliniker. För brustet 
pulsåderbråck finns två huvudsakliga behandlingsalternativ; öppen operation då en 
klämma sätts på pulsåderbråckets hals, eller endovaskulär behandling då kärlet 
behandlas inifrån genom embolisering under röntgengenomlysning. Efter utskrivning 
får en del patienterna rehabilitering, men detta gäller inte alla. 
 
Ungefär 1/3 av dem som drabbas avlider under den första månaden. De som överlever 
kan ha fysiska restsymtom i form av bl.a. rörelsenedsättningar, känselbortfall, 
överväldigande trötthet, epilepsi och hydracefalus. Beskrivna psykologiska restsymtom 
är bl.a. ökad oro och depression, kognitiv nedsättning, personlighetsförändring och 
humörsvängningar. Även sociala konsekvenser finns beskrivna; svårigheter att 
återvända till arbetet, färre sociala aktiviteter och förändrade relationer i familjen. 
Tidigare studier har visat påverkad hälsorelaterad livskvalitet upp till fem år efter 
pulsåderbråcket. I Sverige inkluderas inte patienter med denna typ av stroke i det 
svenska strokeregistret, svensk data om antalet drabbade och uppföljning av dessa 
patienter saknas därför. Många internationella studier har genomförts på patienter som 
drabbats av brustet pulsåderbråck i hjärnan, men få studier har följt patienterna över tid, 
eller följt upp dessa patienter längre än fem år efter bristningen. 
 
Syfte 
Det övergripande syftet för avhandlingen var att beskriva påverkan på livet upp till tio 
år efter brustet pulsåderbråck i hjärnan i termer av hälsorelaterad livskvalitet, 
förändringar i det dagliga livet och beskrivande epidemiologi. 
 
Studie I var en prospektiv longitudinell observationsstudie med syfte att beskriva 
förändringar och övergångar i det dagliga livet under de första två åren efter brustet 
pulsåderbråck. Urvalet togs konsekutivt, 88 personer inkluderades och följdes upp vid 
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tre tillfällen; sex månader, ett år och två år efter brustet pulsåderbråck. Data insamlades 
med ett studiespecifikt frågeformulär och analyserades med mixad metod där både 
kvalitativ- och kvantitativ ansats användes för att ge en fylligare bild av upplevda 
förändringar. Resultatet visade att majoriteten av deltagarna upplevde förändringar i det 
dagliga livet under de första två åren, och förändringarna pågick med liten skillnad över 
tid från sex månader till två år. Omvälvande inre förändringar (övergångar) upplevdes 
med ändrad personlighet, förändrade sociala roller och relationer, ändrade förmågor 
och beteenden. 
 
Studie II var en retrospektiv kohortstudie med kvantitativ ansats, syftet var att beskriva 
epidemiologi i relation till könsskillnader och behandlingsmetoder tio år efter brustet 
pulsåderbråck. Urvalet togs konsekutivt och 468 personer inkluderades. Data 
insamlades från patientjournaler och Dödsorsaksregistret. Resultatet visade att 
incidensen sjönk under åren 1996 till 1999. Incidensen var högre hos kvinnor än hos 
män, de var också äldre när pulsåderbråcket brast och diagnosticerades med fler 
pulsåderbråck. Majoriteten (63.9 %) av patienterna levde tio år efter att pulsåderbråcket 
brustit. Dödligheten första månaden var 19.4 % och vanligaste orsaken var den initiala 
blödningen, efter det första året var de vanligaste dödsorsakerna hjärt-kärlsjukdomar 
och cancersjukdomar. Det fanns inga skillnader i dödlighet eller överlevnadstid mellan 
könen. Överlevnadstiden var likvärdig mellan dem som behandlats aktivt (öppen 
operation eller endovaskulärt). 
 
Studie III var en tvärsnittsstudie med kvantitativ ansats, syftet var att beskriva 
psykologiska, fysiska och kognitiva funktioner tio år efter brustet pulsåderbråck i 
hjärnan, samt att identifiera skillnader i dessa variabler mellan åldergrupper, kön och 
olika lokalisationer för pulsåderbråcket. Urvalet bestod av de personer som var levande 
från urvalet i studie II, 217 personer inkluderades. Data samlades in med enkäter och 
telefonintervjuer. Resultatet visade att graden av oro och symtom på depression var 
högre tio år efter brustet pulsåderbråck än jämfört med i referenspopulationer i tidigare 
publicerade studier. De som haft ett pulsåderbråck i hjärnans bakre cirkulation skattade 
statistiskt högre grad av oro och mer symtom på depression. En liten andel (2.8 %) 
hade svår fysisk nedsättning, majoriteten klarade aktiviteter i dagligt liv självständigt. 
På gruppnivå var den kognitiva funktionen lägre än referenspopulation, 21.7 % hade 
värden under brytpunkten som indikerar nedsatt kognitiv förmåga. 
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Studie IV hade en retrospektiv kohortdesign med kvantitativ ansats. Syftet var att mäta 
hälsorelaterad livskvalitet, och utforska vilka faktorer som påverkar hälsorelaterad 
livskvalitet, tio år efter brustet pulsåderbråck i hjärnan. Samma urval som i studie III 
användes (217 personer), vilka jämfördes med ett matchat urval (434 personer) från 
normalpopulation hämtad från Folkhälsoenkäten i Stockholm 2006. Data insamlades 
med enkäten EQ-5D. Resultatet visade att tio år efter det att pulsåderbråcket brast är 
den hälsorelaterade livskvaliteten statistiskt sämre än hos normalpopulation. De som 
haft pulsåderbråck rapporterade fler och svårare problem med rörlighet, hygien, 
huvudsakliga aktiviteter och oro/nedstämdhet. Mest påverkad hälsorelaterad livskvalitet 
i pulsåderbråcksgruppen påvisades hos deltagare med sämre neurologisk status vid 
utskrivningen från sjukhus efter bristningen, deltagare med övrig sjuklighet och 
deltagare med låg grad av upplevd återhämtning. 
 
Slutsatser 
Resultatet från studierna visar att livet påverkas på flera sätt efter brustet pulsåderbråck; 
under de första två åren fortgår omvälvande förändringar, tio år efteråt är den 
hälsorelaterade livskvaliteten sämre än hos normalpopulation med hög grad av oro och 
symtom på depression. Resultatet indikerar ett behov av uppföljning av patienter som 
drabbats av brustet pulsåderbråck i hjärnan. Uppföljningar behövs för att utvärdera vård 
och behandling, studera epidemiologiska parametrar såsom incidens och mortalitet, och 
för att kunna identifiera patienter som är i behov av stödjande åtgärder. Ytterligare 
studier behövs för att utröna hur dessa patienter ska följas upp och stödjas. 
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